Page last updated: 2024-08-23

etoposide and Lymphoma

etoposide has been researched along with Lymphoma in 414 studies

Research

Studies (414)

TimeframeStudies, this research(%)All Research%
pre-199075 (18.12)18.7374
1990's118 (28.50)18.2507
2000's116 (28.02)29.6817
2010's71 (17.15)24.3611
2020's34 (8.21)2.80

Authors

AuthorsStudies
Kurumurthy, C; Narsaiah, B; Pamanji, R; Sambasiva Rao, P; Santhosh Kumar, G; Shanthan Rao, P; Veera Swamy, B; Velatooru, LR; Venkateswara Rao, J1
Chiba, A; Ebisawa, K; Honda, A; Kurokawa, M; Masamoto, Y; Okazaki, H1
Song, Y; Wang, J; Wang, Y; Wang, Z; Wu, L1
Atalla, A; Costa, LJM; Duarte, FB; Leal, CTS; Neto, AEH; Pereira, J; Sabioni, BS; Tavares, RB1
Ashkenazi, M; Avni, B; Grisariu, S; Lebel, E; Stepensky, P; Vainstein, V; Zimran, E1
Chang, KC; Chen, JS; Cheng, CN; Chu, WY1
An, LC; Chen, LM; Chu, XX; Feng, XY; Li, KM; Liu, XQ; Liu, YH; Ma, JJ; Sui, JR; Wang, JY; Wei, RX; Xu, JQ1
Do, YR; Kang, HJ; Kim, HG; Kim, KH; Kim, WS; Kong, JH; Kwak, JY; Lee, JH; Lee, M; Mun, YC; Oh, SY; Park, MR; Park, SK; Park, Y; Shin, HJ; Won, JH; Yang, DH1
An, G; Deng, S; Fu, M; Huang, W; Jiao, Y; Li, R; Liu, H; Liu, W; Lv, R; Qiu, L; Sui, W; Wang, T; Yi, S; Zhao, Y; Zou, D1
Chen, X; Chu, J; Huang, H; Jiang, Y; Jin, Z; Li, C; Liu, S; Qian, C; Qu, C; Wu, D; Xu, T; Yang, H; Zhang, L; Zhang, X; Zhou, J; Zhu, Q1
Bojalil-Alvarez, L; Fernández-Gutiérrez, JA; Garcia-Villasenor, E; Gomez-Almaguer, D; Gómez-Gomez, ET; Gutierrez-Aguirre, CH; Karduss-Urueta, AJ; Litzow, MR; Murrieta-Alvarez, I; Reyes-Cisneros, OA; Ruiz-Arguelles, GJ; Ruiz-Delgado, GJ1
Abraham, J; Agbetiafa, K; Ahle, G; Bonmati, C; Bouabdallah, K; Bouabdallah, R; Bourget, P; Casasnovas, O; Charron, C; Chauchet, A; Chinot, O; Choquet, S; Cornillon, J; Damaj, G; Delwail, V; Dorvaux, V; Fabbro, M; Fornecker, LM; Ghesquières, H; Giordan, Q; Gressin, R; Gyan, E; Hoang-Xuan, K; Houillier, C; Houot, R; Jabeur, W; Jardin, F; Le Garff-Tavernier, M; Malaise, D; Marolleau, JP; Moluçon-Chabrot, C; Morschhauser, F; Nichelli, L; Oberic, L; Peyrade, F; Plessier, A; Roland, V; Schenone, L; Schmitt, A; Soussain, C; Taillandier, L; Tanguy, ML; Tempescul, A; Thieblemont, C; Touitou, V; Ursu, R; Wantz-Mézières, S; Waultier-Rascalou, A; Willems, L1
Feng, X; Gao, Y; Jin, M; Li, H; Li, Z; Shi, C; Song, W; Zhang, L; Zhang, M1
Chan, EHL; Chan, JYS; Chang, EWY; Chee, YL; de Mel, S; Diong, C; Farid, M; Goh, AZK; Goh, YT; Grigoropoulos, NF; Jeyasekharan, A; Khoo, LP; Lee, J; Lee, YS; Lim, C; Lim, ST; Liu, X; Nagarajan, C; Poon, E; Poon, M; Quek, R; Somasundaram, N; Tan, D; Tang, T; Tao, M; Tay, T; Yang, VSW1
Allione, B; Angelillo, P; Cattaneo, C; Erbella, F; Facchetti, F; Ferreri, AJM; Flospergher, E; Foppoli, M; Lleshi, A; Pagani, C; Pecciarini, L; Ponzoni, M; Re, A; Rossi, G; Sassone, M; Spina, M; Steffanoni, S; Verga, L1
André, M; Berriolo-Riedinger, A; Borel, C; Brice, P; Edeline, V; Feugier, P; Gac, AC; Gastinne, T; Ghesquières, H; Guidez, S; Le Bras, F; Morschhauser, F; Nicolas-Virelizier, E; Quittet, P; Ribrag, V; Stamatoullas, A; Vander Borght, T1
Cui, T; Meng, G; Wang, J; Wang, Z1
Fei, XM; Lei, F; Lu, WP; Wang, LX; Yu, XQ1
Chang, Y; Fu, X; Li, L; Li, X; Lin, M; Nan, F; Shi, C; Sun, Z; Wang, X; Wu, X; Yan, J; Yu, H; Zhang, L; Zhang, M; Zhang, X; Zhou, Z; Zhu, L1
Avni, B; Cohen, YI; Grisariu, S; Lebel, E; Shaulov, A; Stepensky, P; Zimran, E1
Beleggia, F; Borkhardt, A; Burdach, S; Büttner, R; Frenzel, LP; Fritz, C; Geyer, A; Grüll, H; Hansmann, ML; Heneweer, C; Jachimowicz, RD; Klapper, W; Knittel, G; Krüger, M; Lehrmann, D; Mall, G; Merseburg, A; Ortmann, M; Paillard, A; Peifer, M; Perner, S; Persigehl, T; Reinhardt, HC; Riabinska, A; Rosenwald, A; Schmitt, A; Torgovnick, A; Utermöhlen, O; Wiederstein, JL; Wittersheim, M; Wößmann, W; Wunderlich, CM; Wunderlich, FT1
An, HY; Choi, JY; Hong, KT; Kang, HJ; Shin, HY1
Ballotta, L; Capria, S; Celentano, M; Ferrara, F; Marchesi, F; Mengarelli, A; Papa, E; Pedata, M; Picardi, A; Regazzo, G; Riccardi, C; Riemma, C; Terrenato, I; Trisolini, S1
Difilippantonio, S; Huang, SN; James, A; Marzi, L; Pommier, Y; Sun, Y1
Chen, C; Gao, Y; Guan, Z; Li, M; Liu, Y; Pan, X; Qiu, S; Wang, H; Wen, Z; Yang, S; Yuan, Y; Zeng, W; Zhang, H; Zhou, L; Zhu, Q1
Fukuhara, N; Imaizumi, Y; Izutsu, K; Matsuda, S; Miyazaki, K; Nakazato, T; Shimada, K; Suehiro, Y; Suzuki, R; Suzumiya, J; Takahashi, T; Tomita, N; Yamaguchi, M; Yoshida, I1
Kelsey, P; Kirkland, K; Lambert, J; Malladi, R; Morley, N; Paul, R; Pearce, R; Peniket, A; Perry, J; Snowden, JA1
Chen, CK; Hayashi, S; Ikari, K; Kusano, J; Ogai, A; Ozawa, Y; Yamamoto, R; Yoshida, R1
Chong, SJF; Collins, M; Davids, M; Herbaux, C; Iskandar, K; Lai, JXH; Loh, T; Low, ICC; Pervaiz, S; Qu, J; Raman, D; Valentin, R1
Chen, J; Liu, L; Luo, X; Tang, X; Wang, L; Wang, X; Xiao, Q; Xiong, Y; Zhang, H1
Fuji, S; Ohmoto, A1
Akkurt, DM; Cinli, TA; Demir, I; Durusoy, SS; Gunes, AK; Ince, I; Ozkan, G; Pehlivan, M; Sarifakiogullari, S; Serin, I1
Birkmann, J; Blaudszun, AR; Bornhäuser, M; Ehninger, G; Fiedler, F; Fricke, S; Hänel, A; Hänel, M; Herbst, R; Kroschinsky, F; Kürzel, S; Schaefer-Eckart, K; Stahl, L1
Ou, Y; Sun, G; Wang, H; Zhang, Z1
Bouchaert, E; Boyé, P; Gomes, B; Hordeaux, J; Marescaux, L; Serres, F; Tierny, D1
Eldeeb, MA; Fahlman, RP; Kramer, DA; Mercer, J; Wuest, M1
Batlle, M; Feliu, E; Ferra, C; Garcia, O; Ibarra, G; Lopez, D; Moreno, M; Pineda, A; Ribera, JM; Sancho, JM; Sorigue, M; Tapia, G; Vives, S1
Deng, SH; Fu, MW; Huang, WY; Li, J; Li, ZJ; Liu, H; Liu, W; Lv, R; Qiu, LG; Sui, WW; Wang, TY; Zou, DH1
Andresen, S; Bolwell, B; Copelan, E; Dean, R; Hamilton, B; Hill, B; Kalaycio, M; Khouri, J; Lazaryan, A; Liu, H; Majhail, N; Pohlman, B; Rybicki, L; Sobecks, R1
Beejadhursing, R; Feng, L; He, M; Jia, J; Mwamaka Sharifu, L; Wang, S; Yu, J; Zhang, J1
Aoyama, T; Arai, H; Ikeda, T; Imataki, O; Ishide, K; Katsumata, N; Kume, T; Mori, M; Shiozaki, H1
Birsen, R; Blanc, E; Bouscary, D; Burroni, B; Damotte, D; Deau, B; Dezamis, E; Edjlali, M; Franchi, P; Houillier, C; Kirova, Y; Le Ray, E; Legoff, M; Pallud, J; Pilorge, S; Soussain, C; Tamburini, J; Varlet, P; Vignon, M; Willems, L1
Iseki, T; Mimura, N; Mitsukawa, S; Muto, T; Nagao, Y; Nakaseko, C; Ohwada, C; Oshima-Hasegawa, N; Ota, S; Sakaida, E; Takaishi, K; Takeda, Y; Takeuchi, M; Takiguchi, J; Tsukamoto, S1
Boehm, A; Keil, F; Koller, E; Menschel, E; Moestl, M; Noesslinger, T; Panny, M; Simanek, R1
Billio, A; Borghero, C; Calimeri, T; Carli, G; Cascavilla, N; Centurioni, R; Chiusolo, P; Codeluppi, K; Fama, A; Fanin, R; Federici, I; Ferrero, S; Finotto, S; Gherlinzoni, F; Ghione, P; Giannoccaro, M; Lanza, F; Loseto, G; Marino, D; Matera, R; Mazzone, AM; Mosna, F; Olivieri, A; Olivieri, J; Orciuolo, E; Pelosini, M; Perali, G; Rattotti, S; Saraceni, F; Sgherza, N; Sica, S; Stefani, PM; Tisi, MC; Tomei, G; Zaja, F1
Bettarello, G; Costa, LJM; da Matta Abreu, M; Dos Santos, KB; Hallack Neto, AE; Mayrink, GTC; Mota, MA; Pereira, J; Ribeiro, LC1
Kimpton, G; Maybury, B; Otton, S1
Aboulafia, D; Ambinder, RF; Cesarman, E; Henry, D; Lee, J; Looney, D; Maldarelli, F; Mitsuyasu, R; Noy, A; Ramos, JC; Reid, EG; Sparano, J; Wachsman, W; Yahyaei, S1
Chen, J; Huang, H; Jiang, Y; Jin, Z; Liu, S; Ruan, J; Wu, D; Xiao, X; Zhang, L; Zhang, X1
Hong, JY; Huh, J; Hyung, J; Kim, JH; Kim, S; Lee, SW; Park, CS; Park, JS; Ryu, JS; Suh, C; Yoon, DH1
Castro, M; Cia, A; Duarte, P; Foncuberta, C; Gale, RP; Jaimovich, G; Lastiri, F; Longoni, H; Ostriz, MBR; Riera, L; Vitriu, A1
Ayarza, M; Clark, SM; Hairston, A; Lentz, KL; Liu, B; Morgan, KP; Wind, LS1
Dys, P; Jurek, T; Rorat, M; Swiatek, B1
Bohndiek, SE; Booth, TC; Brindle, KM; Canuto, HC; Hobson, MP; Hu, DE; Kettunen, MI; Krishnan, AS; Larkin, TJ; McLachlan, C; Neves, AA1
Calandrelli, M; Capelli, D; Chiarucci, M; Gini, G; Inglese, E; Leoni, P; Mancini, G; Mancini, S; Montanari, M; Offidani, M; Olivieri, A; Poloni, A; Raggetti, G; Scortechini, I1
Couez, D; Delneste, Y; Donnou, S; Fremaux, I; Jarry, U; Jeannin, P; Pineau, L; Vincent, M1
Aumont, C; Coppo, P; Fardet, L; Galicier, L; Lambotte, O; Marzac, C; Rivière, S1
Atalla, A; Costa, LJ; dos Santos, KB; Hallack-Neto, AE; Pereira, J1
D'Sa, S; Dorman, J; Marzolini, MA; Thomson, KJ1
Bai, L; Greenwood, M; Kerridge, I; Ma, CK; Reid, C; Ward, C; Wong, K; Xia, W1
Atanasova, T; Ilieva, Y; Ionkova, I; Konstantinov, S; Sasheva, P; Zaharieva, MM; Zhelezova, I1
Abe, Y; Choi, I; Haji, S; Kiyasu, J; Ohshima, K; Suehiro, Y; Toyoda, K; Tsuda, M; Uike, N1
Barriere, J; Borchiellini, D; Boscagli, A; Coso, D; Garnier, G; Gastaud, L; Gutnecht, J; Martin, N; Naman, H; Petit, E; Peyrade, F; Re, D; Rossignol, B; Saudes, L; Thyss, A1
Dehoedt, C; Jin, F; Li, F; Li, P; Rao, J; Wang, M; Yang, G; Yang, Y; Zhang, R; Zhou, Y1
Ford, PA; Grant, SJ; Keck, G; Mick, R1
Dietrich, S; Ho, AD; Katzke, V; Kühn, T; Kuhnt, E; Meissner, J; Pfreundschuh, M; Rixecker, T; Schmitt, T; Tichy, D; Witzens-Harig, M; Ziepert, M; Zorn, M1
Dong, F; Ke, X; Pang, Y; Wang, J1
Gui, L; Han, XH; He, XH; Liu, P; Qin, Y; Shi, YK; Sun, Y; Yang, S; Yao, JR; Zhang, CG; Zhang, SX; Zhao, LY; Zhou, P; Zhou, SY1
Frey, NV; Ganetsky, A; Landsburg, DJ; Loren, AW; Luger, SM; Luskin, MR; Nasta, SD; Porter, DL; Svoboda, J1
Duan, L; Li, J; Qiu, H; Tian, T; Wang, D; Wang, J; Zhang, Q; Zhang, X1
Arakelyan, S; Avagyan, A; Bardakchyan, S; Danielyan, S; Hakobyan, L; Harutyunyan, L; Iskanyan, S; Safaryan, L; Sargsyan, L; Tamamyan, G; Voskanyan, A; Zohrabyan, D1
Ai, W; Bence-Bruckler, I; Bierman, P; Braunschweig, I; Chen, AI; Comeau, T; Costa, LJ; Craig, M; Fay, JW; Flinn, I; Flowers, CR; Freytes, CO; Horwitz, ME; Kato, K; Laneuville, P; Le-Rademacher, J; Lill, M; Mason, J; Mineishi, S; Pasquini, MC; Pulsipher, MA; Rodriguez, TE; Rondelli, D; Shea, TC; Shore, TB; Smith, AJ; Vaughan, W; Waller, EK; Wang, Y; Xu, C; Yeager, AM; Yeh, RF1
Hotta, T; Kubo, K; Miyazaki, Y; Murayama, T; Shimazaki, R; Tamura, K; Urabe, A; Usui, N1
Ardeshna, KM; Foley, M; Kothari, J; Lambert, J; Linch, DC; Mackenzie, S; Morris, E; Peggs, KS; Thomson, K; Virchis, AE1
Andresen, S; Bolwell, BJ; Carlstrom, KD; Dean, R; Gerds, A; Hamilton, B; Hill, BT; Jagadeesh, D; Kalaycio, M; Liu, H; Majhail, NS; Pohlman, B; Rybicki, L; Sobecks, R1
Ashizawa, M; Fujiwara, S; Hatano, K; Ito, S; Kako, S; Kanda, Y; Kawasaki, Y; Mashima, K; Minakata, D; Muroi, K; Nakano, H; Oh, I; Ohmine, K; Okazuka, K; Sato, K; Sugimoto, M; Suzuki, T; Umino, K; Yamamoto, C; Yamasaki, R1
Cheah, CY; Chihara, D; Fanale, MA; Fayad, LE; Fowler, NH; Hagemeister, FB; Medeiros, LJ; Miranda, RN; Nastoupil, LJ; Neelapu, SS; Oki, Y; Orlowski, RZ; Rodriguez, MA; Romaguera, JE; Turturro, F; Wang, M; Westin, JR1
Chihara, D; Fanale, MA; Fayad, LE; Fowler, NH; Hagemeister, FB; Oki, Y; Westin, JR1
Abboud, C; Cashen, AF; Ceriotti, C; DiPersio, J; Fletcher, T; Gao, F; Ghobadi, A; Stockerl-Goldstein, K; Vij, R1
Accordino, MK; Hershman, DL; Hillyer, GC; Neugut, AI; Vasan, S; Wright, JD1
Borlak, J; Reymann, S1
Cook, G; Crawley, C; Fields, P; Hickling, R; Hunter, A; Mahendra, P; Marcus, R; Peniket, A; Wilson, K1
Brindle, KM; Day, SE; Fulton, SM; Gallagher, FA; Hu, DE; Kettunen, MI; Neves, AA; Witney, TH1
Barzal, J; Mlot, B; Oborska, S; Pielichowski, W; Rzepecki, P1
Cascavilla, N; Crescimanno, A; Di Bartolomeo, P; Di Renzo, N; Lanza, F; Marcacci, G; Musso, M; Perrone, T; Pinto, A; Scalone, R1
Bohndiek, SE; Brindle, KM; Gallagher, FA; Gisselsson, A; Hansson, G; Hu, DE; Jensen, PR; Karlsson, M; Kettunen, MI; Lerche, MH; Nelson, SK; Peitersen, T; Witney, TH; Zandt, RI1
Biron, P; Blay, JY; Bosly, A; Casasnovas, O; Coiffier, B; Colin, P; Ferlay, C; Ghesquières, H; Haioun, C; Morel, P; Perol, D; Reman, O; Sebban, C; Tilly, H; Van den Neste, E1
Baldini, L; Barbolini, E; Brugiatelli, M; Dell'Olio, M; Dondi, A; Federico, M; Giglio, G; Gobbi, PG; Luminari, S; Mannina, D; Merli, F; Polimeno, G; Stelitano, C1
Avilés, A; de Jesús Nambo, M; Huerta-Guzmán, J; Neri, N1
Choi, DR; Huh, J; Kim, S; Kim, SW; Lee, DH; Lee, JS; Lee, SW; Sohn, BS; Suh, C; Yoon, DH1
Abboud, CN; Becker, MW; Bernstein, SH; Constine, LS; Friedberg, JW; Ifthikharuddin, JJ; Liesveld, JL; Loughner, JE; Milner, LA; Phillips, GL; Vesole, DH1
Andresen, S; Bolwell, B; Copelan, E; Copelan, O; Dean, R; Duong, H; Figueroa, P; Kalaycio, M; Koo, A; Malik, S; Pohlman, B; Rybicki, L; Sobecks, R; Sweetenham, J; Tench, S1
Andresen, S; Avalos, B; Bolwell, BJ; Copelan, E; Dean, R; Devine, S; Elder, P; Kalaycio, M; Mahindra, A; Pohlman, B; Rybicki, L; Sobecks, R; Sweetenham, J; Tench, S1
Ashizawa, M; Kako, S; Kanda, Y; Kikuchi, M; Kimura, S; Nakasone, H; Nishida, J; Okuda, S; Oshima, K; Sakamoto, K; Sato, M; Terasako, K; Wada, H; Yamazaki, R1
Balzer, RJ; Champlin, R; de Lima, M; Giralt, S; Hosing, C; Khouri, I; McMannis, J; Popat, U; Qazilbash, M; Rhodes, B; Smith, V; Thompson, R; Walters, K1
Choquet, S; del Rio, MS; Fourme, E; Glaisner, S; Hoang-Xuan, K; Janvier, M; Soussain, C1
Fujii, M; Ito, M; Momota, H; Motomura, K; Natsume, A; Wakabayashi, T1
Chang, HC; De La Rosa, M; Han, L; Lupov, IP; Oza, K; Pelloso, D; Robertson, MJ; Sahu, RP; Schwartz, A; Travers, JB; Voiles, L1
Abramson, JS; Armand, P; Brown, JR; Chen, YB; Feng, Y; Fisher, DC; Freedman, AS; Jacobsen, ED; LaCasce, AS; Lane, AA; McAfee, SL; Neuberg, DS; Spitzer, TR1
Madtes, DK; Till, BG1
Behler, CM; Cha, S; Damon, LE; Hwang, J; Issa, S; McDermott, M; O'Brien, J; Rubenstein, JL; Shuman, MA; Treseler, P; Valles, F; Wieduwilt, MJ1
Bishop, MR; Bryant, K; Dean, RM; Dunleavy, K; Fowler, DH; Fry, TJ; Gress, RE; Hakim, F; Hughes, TE; Odom, J; Pavletic, SZ; Salit, RB; Steinberg, SM; Wilson, WH1
Berger, SA; Li, H; Martin, A; Nepal, RM1
Ali, Z; Dada, MO; Flowers, CR; Graiser, M; Hutcherson, DA; McMillan, S; Waller, EK; Zhang, H1
Degnan, AJ; Levy, LM1
Coleman, M; Elstrom, RL; Leonard, JP; Martin, P; Ruan, G1
Anderson, DJ; Belmont, LD; Bouillet, P; Campbell, KJ; Cory, S; Fairlie, WD; Glaser, SP; Huang, DC; Khaw, SL; Lee, EF; Ludlam, MJ; Mérino, D; Phipson, B; Robati, M; Roberts, AW; Vandenberg, CJ; Wong, C; Yue, P1
Happo, L; Phipson, B; Scott, CL; Smyth, GK; Strasser, A1
Cavallini, S; Mariani, L; Rainaldi, G; Rizzo, M; Simili, M1
Boyd, TE; Budde, LE; Chen, TL; Frayo, SL; Gooley, TA; Gopal, AK; Kammerer, BE; Knudsen, NL; Oliveira, GR; Pagel, JM; Press, OW; Roden, JE; Shustov, AR; Warr, TA; Zhang, MM1
Alinari, L; Baccarani, M; Bonifazi, F; Gabriele, A; Molinari, AL; Salvucci, M; Stefoni, V; Tani, M; Tura, S; Zinzani, PL; Zuffa, E1
Crump, M; Keating, A; Mollee, P; Nagy, T; Pereira, D; Saragosa, R; Song, K1
Grigg, AP; Ritchie, DS; Roberts, AW; Shuttleworth, P; Szer, J1
D'Orazio, A; Gibson, AD1
Emmanouilides, C; Grody, W; Lill, M; Rosen, P; Rosenfelt, F; Telatar, M; Territo, M1
Staudt, LM; Wilson, WH1
Ben-Schachar, M; Epelbaum, R; Haim, N; Kuten, A; Stein, ME; Zaidan, J1
Bökönyi, G; Horváth, A; Kéri, G; Szende, B1
Aoki, Y; Kataoka, C; Nomiyama, K; Shibuya, T1
Briggs, A; Chow, HH; Dorr, RT; Kintzel, P; List, A; Meyers, R1
Doolittle, ND; Kraemer, DF; Lacy, C; Neutwelt, EA; Siegal, T; Tyson, RM1
Chang, MC; Chao, TY; Chen, LT; Chen, PJ; Cheng, AL; Hsiung, CA; Hsu, CH; Kao, WY; Su, IJ; Tien, HF; Tsao, CJ; Uen, WC; Whang-Peng, J1
Aylott, M; Burman, M; Harvey, J; Lynch, A; Nicholas, E; Rees, R; Siddiqui, A; Walker, S1
Kagami, Y; Miura, K; Morishima, Y; Ogura, M; Suzuki, R; Taji, H; Takeuchi, T1
Duncan, A; Lachance, S; Mangel, J1
Shacter, E; Zhang, B; Zhang, Y2
Au, WY; Chan, EC; Kwong, YL; Leung, AY; Liang, R; Lie, AK; Ooi, GC; Siu, LL1
Fil'chenkov, AA; Nesina, IP; Smirnova, IA; Zavelevich, MP1
Hanioka, K; Maeda, A; Matsushita, A; Nagai, K; Sugimoto, N; Takahashi, T; Watanabe, N1
Caballero, MD; del Cañizo, MC; García-Sanz, R; López, N; Martín, A; Pérez-Simón, JA; San Miguel, JF; Vázquez, L1
Aibe, H; Asayama, Y; Honda, H; Irie, H; Kakihara, D; Matake, K; Nakamura, K; Nakayama, T; Nishie, A; Ohga, S; Tajima, T; Yamamoto, N; Yoshimitsu, K1
Ballestrero, A; Boy, D; Brossart, P; Garuti, A; Mela, GS; Nencioni, A; Patrone, F; Rocco, I; Van Parijs, L; Wesselborg, S1
Avalos, B; Bechtel, T; Copelan, E; Elder, P; Ezzone, S; Farag, S; Hoshaw-Woodard, S; Lemeshow, S; Lin, T; Marcucci, G; Penza, S; Scholl, MD1
Ball, ED; Bashey, A; Carrier, E; Chen, YA; Corringham, S; Holman, P; Wang, EH1
Becker, E; Casper, J; Franke, A; Freund, M; Heim, M; Jentsch-Ullrich, K; Koenigsmann, M; Mohren, M1
Holte, H; Jerkeman, M; Kvaløy, S; Leppä, S1
Caballero, MD; Cañizo, MC; López-Holgado, N; Martín, A; Mateos, MV; Miguel, JF; Pérez-Simón, JA1
Ikarashi, Y; Imai, C; Kakihara, T; Tanaka, A; Uchiyama, M; Watanabe, A1
Baldinger, C; Fridrik, MA; Greil, R; Hausmaninger, H; Klocker, J; Krieger, O; Linkesch, W; Oberaigner, W; Pont, J1
Aydin, F; Bektas, O; Kavgaci, H; Ozdemir, F; Yavuz, AA; Yavuz, MN; Yilmaz, M1
Berg, SL; Bessmertny, O; Cairo, MS; Davenport, V; Goldman, SC; Kreissman, SG; Laver, J; Reaman, GH; Secola, R; Shen, V; van de Ven, C1
Abdi, E; Biagi, JJ; Dale, B; Falkson, C; Herbert, KE; Januszewicz, H; Leahy, M; Matthews, JP; Prince, HM; Richards, K; Seymour, JF; Smith, C; Wolf, M1
Caballero, MD; del Cañizo, MC; López-Holgado, N; Martín, A; Pérez-Simón, JA; San Miguel, JF; Vázquez, L1
Boxer, LM; Wang, J1
Abboud, CN; Bernstein, SH; Chapman, M; Friedberg, JW; Ifthikharuddin, JJ; Johnson, V; Lancet, JE; Liesveld, JL; Phillips, GL; Spreng, E; Vesole, DH1
Hondoh, H; Morii, K; Onda, K; Shinbo, Y; Takahashi, H; Takeuchi, S; Tamura, T; Tanaka, R; Yamanaka, R1
Ariyoshi, Y; Fukuoka, M; Furuse, K; Hatae, M; Hirabayashi, K; Noda, K; Ogawa, M; Takaku, F; Yakushiji, M1
Behringer, D; Bertz, H; Finke, J; Küttler, T; Samek, E; Spyridonidis, A; Wäsch, R; Waterhouse, M1
Chuttani, K; Harivardhan Reddy, L; Mishra, AK; Murthy, RS; Sharma, RK1
Abali, H; Barista, I; Demirkazik, F; Kansu, E; Kars, A; Koc, Y; Oyan, B; Tekin, F; Tekuzman, G; Turker, A; Uner, A1
Nishida, T; Oguma, T; Ono, T; Sato, M; Tadakuma, T; Tsujimoto, K1
Brindle, KM; Hu, DE; Kettunen, MI; Schmitz, JE1
Dagher, MC; Shacter, E; Zhang, B; Zhang, Y1
Cai, Z; Huang, H; Li, L; Lin, MF; Luo, Y; Meng, XJ; Xie, WZ1
Brevet, M; Damaj, G; Garidi, R; Gruson, B; Royer, B; Vaida, I1
Takahashi, H; Tanaka, R1
Cho, JH; Kim, HS; Ko, YH; Park, CS1
Earnshaw, WC; Kaufmann, SH; Loegering, DA; Ruchaud, S1
Berdel, WE; Dorken, B; Glass, B; Kloess, M; Kneba, M; Loeffler, M; Metzner, B; Pfreundschuh, M; Reiser, M; Schmitz, N; Trumper, L1
Abali, H; Dizdar, O; Erdem, I; Eren, OO; Erman, M; Karadağ, O; Türker, A; Uluç, K; Yilmaz, A1
Horiike, S; Kanbayashi, Y; Matsumoto, Y; Mukoyama, N; Nishida, K; Nomura, K; Shimizu, D; Taniwaki, M1
Akbulut, T; Boulares, H; Kandan, S; Oumouna, M; Yakovlev, A; Zoltoski, A1
Aoki, S; Hirano, M; Miura, I; Niitsu, N; Okamoto, M; Okumura, H; Yoshino, T1
Beguin, Y; Fillet, G; Frère, P; Ngirabacu, MC; Vanstraelen, G; Willems, E1
Murthy, RR; Reddy, LH; Sharma, RK1
Adhikari, JS; Dwarakanath, BS; Murthy, RR; Reddy, LH; Sharma, RK1
Björkholm, M; Celsing, F; Johansson, E1
Akutsu, M; Furukawa, Y; Izumi, T; Kano, Y; Kobayashi, H; Mano, H; Tsunoda, S1
Blechschmidt, M; Bornhäuser, M; Ehninger, G; Hänel, M; Hölig, K; Kroschinsky, F; Oelschlaegel, U; Ordemann, R; Platzbecker, U; Poppe-Thiede, K; Schaich, M1
Bay, JO; Berthou, C; Bertrand, P; Brion, A; Camilleri-Broët, S; Colombat, P; Delepine, R; Delwail, V; Desablens, B; Lamy, T; Lemevel, A; Linassier, C; Rachieru, P1
Kansu, E; Kars, A; Koc, Y; Oyan, B; Ozdemir, E; Tekuzman, G; Turker, A1
Arellano, M; Flowers, C; Heffner, LT; Hutcherson, D; Jo Lechowicz, M; Langston, A; Lonial, S; Waller, EK; Winton, E1
Boudrias, M; Fortin, D; Garant, MP; Gendron, C1
Ebeling, P; Metz, K; Moritz, T; Müller, S; Nowrousian, MR; Passon, J; Schütt, P; Seeber, S; Welt, A1
Arber, C; Bucher, C; Buser, AS; Ghielmini, M; Gratwohl, A; Halter, J; Heim, D; Lohri, A; Meyer-Monard, S; Passweg, JR; Stern, M; Stussi, G; Tichelli, A1
Homma, J; Hondoh, H; Morii, K; Onda, K; Sano, M; Shinbo, Y; Takahashi, H; Tamura, T; Tanaka, R; Tsuchiya, N; Yajima, N; Yamanaka, R1
Ference, SJ; Galor, A; Lee, MS; Peereboom, DM; Perez, VL; Singh, AD; Stevens, GH1
Hardan, I; Shimoni, A1
Avola, G; Battiato, K; Camuglia, MG; Coppoletta, S; Giustolisi, R; Leotta, S; Mauro, E; Mercurio, S; Milone, G; Murgano, P; Pinto, V; Poidomani, M; Strano, A1
Imataki, O; Kawakami, K; Tamai, Y1
Aoyama, T; Imataki, O; Kawakami, K; Tamai, Y1
Ardenkjaer-Larsen, JH; Brindle, KM; Day, SE; Gallagher, FA; Golman, K; Hu, DE; Kettunen, MI; Lerche, M; Wolber, J1
Fujioka, K; Funabiki, T; Goto, H; Goto, S; Hanzawa, N; Ikuta, K; Izaki, S; Kai, S; Matsuda, M; Okuda, K; Sasaki, H; Sekiguchi, H; Sumita, H; Takahashi, H; Watanabe, Y; Yokota, S1
Goldstein, DA; Tessler, HH1
Brindle, KM; Davletov, B; de Backer, MM; Hu, DE; Kettunen, MI; Krishnan, AS; Neves, AA1
Coleman, M; Elstrom, R; Furman, R; George, P; Kaufman, TP; Leonard, JP; Martin, P; Niesvizky, R; Ruan, J1
Grifols, JR; Juncà, J; Morgades, M; Ribera, JM; Sancho, JM; Vives, S1
Bishton, MJ; Fox, CP; Haynes, AP; McMillan, AK; Russell, NH1
Homma, J; Hondoh, H; Kakuma, T; Morii, K; Sano, M; Shinbo, Y; Takahashi, H; Tamura, T; Tanaka, R; Tsuchiya, N; Yajima, N; Yamanaka, R1
Bodey, GP; Burgess, MA; Cabanillas, F; Freireich, EJ1
Barlogie, B; Cabanillas, F; Freireich, EJ; Keating, M1
Kennedy, BJ; Raghavan, D; Vogelzang, NJ1
Heinz, R; Stacher, A1
Płuzańska, A; Robak, T1
Dicke, KA; Hagemeister, FJ; Jagannath, S; Kanojia, M; McLaughlin, P; Spitzer, G; Tannir, NM; Vellekoop, L; Zander, AR1
Hattori, K; Ito, K; Kobayashi, S; Nakamura, S; Nakanishi, J; Ohtake, S; Yoshida, T1
Adachi, K; Horikoshi, N; Ingaki, J; Inoue, K; Mukaiyama, T; Nakada, H; Ogawa, M; Tada, A; Usui, N; Yamazaki, H1
Chabner, BA; DeVita, VT; Fisher, RI; Hubbard, SM; Longo, DL; Wesley, R; Young, RC1
Berg, C; Bottino, G; Chabner, B; Doyle, LA1
Bremer, K; Niederle, N; Scheulen, ME; Seeber, S1
Fukuoka, M; Kimura, I; Kuraishi, Y; Ogawa, M; Ohnoshi, T; Ota, K; Oyama, A; Sanpi, K; Takada, M; Yoshida, S1
Hayashi, K; Nishihara, R; Onoshi, T; Toyota, K; Ueoka, H1
Ferrazzi, E; Fiorentino, MV; Fosser, VP; Pappagallo, GL; Salvagno, L; Segati, R; Sileni, VC1
Brennan, MF; Fisher, RI; Popp, MB; Simon, RM1
Jungi, WF; Kroner, T; Obrecht, JP1
Nagel, GA; Scherpe, A; von Heyden, HW1
Arnold, AM; Whitehouse, JM1
Barrett, A; McElwain, TJ; Peckham, MJ; Taylor, RE1
Bodey, GP; Cabanillas, F; Freireich, EJ; Hagemeister, FB1
Dicato, M1
Csoka, K; Larsson, R; Liliemark, J; Nygren, P1
Chang, J; Crowther, D; Morgenstern, GR; Pettengell, R; Radford, JA; Rowlands, M; Scarffe, JH; Testa, NG; Woll, PJ; Young, R1
Chan, T; Cooper, I; Januszewicz, E; Juneja, S; Wolf, M1
Cerny, T; Fey, M; Honegger, H; Jacky, E; Jost, LM; Pichert, G; Platzer, E; Stahel, RA; Tobler, A1
Hirano, M1
Ariyama, Y; Fujii, H; Nakagawa, H; Sonoda, Y1
Fuchsberger, P; Lakota, J1
Fehr, J; Rüegg, R; Schleiffenbaum, B; Zimmermann, D1
Ben-Shahar, M; Epelbaum, R; Haim, N1
Ichikawa, Y; Kawada, H; Mukaiyama, T; Ogawa, Y; Watanabe, S1
Bernstein, E; Brodsky, I; Bulova, S; Crilley, P; Marks, DI; Mullaney, R; Resnick, K; Styler, MJ; Topolsky, D1
Alvarez, M; Dickstein, B; Kang, YK; Lee, JS; Meadows, B; Otsuki, T; Regis, J; Robey, R; Stetler-Stevenson, M; Zhan, Z1
Balis, FM; Bates, SE; Bryant, G; Chabner, BA; Jamis-Dow, C; Klecker, RW; Kohler, DR; Steinberg, SM; Wilson, WH; Wittes, RE1
Bates, SE; Bryant, G; Fojo, A; Herdt, J; Jaffe, ES; Regis, J; Steinberg, SM; Wilson, WH; Wittes, RE; Zhan, Z1
Fujii, H; Kuzuyama, Y; Maekawa, T; Nakagawa, H; Sonoda, Y1
Watkins, SM1
Boccadoro, M; Bondesan, P; Bregni, M; Caracciolo, D; Frieri, R; Gianni, AM; Omedé, P; Pileri, A; Siena, S; Tarella, C1
Bertini, M1
Dreger, P; Eckstein, V; Haferlach, T; Jacobs, S; Löffler, H; Marquardt, P; Müller-Ruchholtz, W; Mülverstedt, T; Schmitz, N; Suttorp, M1
Collins, R; Fay, J; Herzig, G; Pineiro, L1
Amylon, MD; Blume, KG; Chao, NJ; Kusnierz-Glaz, C; Long, GD; Negrin, RS1
Cavalli, F; Cerny, T; De Fusco, M; De Jong, J; Gentili, D; McDaniel, C; Pagani, O; Prins, C; Sessa, C; Zucchetti, M1
Bosl, GJ; Chaganti, RS; Mazumdar, M; Motzer, RJ; Reuter, VE; Rodriguez, E1
Daly, MB; Giguere, JK; Harden, EA; Harman, GH; Johnson, DB; Johnson, RA; Leff, RS; Mercier, RJ; Messerschmidt, GL; Snyder, MJ1
Blaschke, TF; Blume, KG; Chao, NJ; Horning, SJ; Kastrissios, H; Long, GD; Negrin, RS; Wong, RM1
Anasetti, C; Bensinger, WI; Buckner, CD; Clift, RA; Demirer, T; Lilleby, K; Martin, P; Petersen, FB; Sanders, J; Weaver, CH1
Cabanillas, F; Hagemeister, FB; Hill, D; McLaughlin, P; Moore, DF; Rodriguez, MA; Romaguera, JE; Sarris, AH; Swan, F; Younes, A1
Hashimoto, S; Hasuike, T; Hirai, M; Hirai, N; Kou, KR; Ohta, K; Ohta, T; Takekawa, K; Tanaka, K; Yamane, T1
Ashihara, E; Fujita, N; Goto, H; Hirata, T; Inaba, T; Nakagawa, M; Okawa, K; Oku, N; Shimazaki, C; Yamagata, N1
Adkins, DR; Boldt, D; Freytes, CO; Irvin, R; Kuhn, J; LeMaistre, CF; Lyons, R; Roodman, GD; Salzman, D; Smith, L1
Barbot, C; Jazwiec, B; Mahon, FX; Reiffers, J; Rice, A; Vanès, I1
Ashby, J; Callander, RD; Clive, D; Glover, P; Krehl, R; Poorman-Allen, P; Tinwell, H1
Chatterjee, R; Goldstone, AH; Katz, M; McGarrigle, HH; Mills, W1
Aisner, J; Belani, CP; Doyle, LA1
Muggia, FM1
Joel, SP; Shah, R; Slevin, ML1
Cabanillas, F; Rodriguez, MA1
Andersson, BS; Dimopoulos, M; Gajewski, J; Giralt, SA; Khouri, I; LeMaistre, CF; Mehra, R; Przepiorka, D; Van Besien, K; Vriesendorp, HM1
Cahill, R; Deeg, HJ; Gadner, H; Ortlieb, M; Peters, C; Spitzer, TR; Tefft, MC; Torrisi, J; Urban, C1
Cabanillas, F; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, J; Rubenstein, E; Swan, F; Tucker, S; Velasquez, WS1
Attal, M; Canal, P; Chatelut, E; Dezeuze, A; Huguet, F; Laurent, G; Payen, C; Pris, J; Schlaifer, D1
Anasetti, C; Appelbaum, FR; Bensinger, W; Bianco, J; Clift, R; Martin, P; Petersen, FB; Press, O; Singer, J; Weaver, CH1
Bulova, SI; Ciobanu, N; Cooper, BW; Creger, RJ; Crilley, P; Fox, RM; Gucalp, R; Lazarus, H; Shina, DC; Topolsky, D1
Caronia, F; Gentile, S; Indovina, A; Liberti, G; Majolino, I; Patti, C; Pisa, R; Santoro, A; Scimè, R; Vasta, S1
Denzlinger, C; Gerhartz, HH; Walther, J; Wilmanns, W1
Gondo, H; Harada, M; Matsuishi, H; Omori, F; Otsuka, T; Shibuya, T; Taniguchi, S; Teshima, T; Yamano, Y; Yamazaki, K1
Johnson, PW; Lister, TA; McCallum, P; Norton, AJ; Rohatiner, AZ; Sweetenham, JW1
Carlson, K; Hagberg, H; Oberg, G; Simonsson, B; Smedmyr, B1
Smith, RJ; Sweetenham, JW1
Cabanillas, FC; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, JE; Swan, F; Velasquez, W1
Goldstone, AH; Linch, DC; Mills, W; Strang, J1
Brummett, RE; Dahlborg, SA; Dana, BW; Henner, WD; Neuwelt, EA; Roman-Goldstein, S; Tableman, M; Williams, PC1
Andrews, F; Bolwell, B; Collins, R; Fay, J; LeFever, A; Levitt, D; List, A; Nemunaitis, J; Pallansch, P; Resta, D; Rosenfeld, CS; Schuster, MW; Taylor, R1
Fujioka, S; Kato, K; Tomono, H1
Xu, J; Zhang, X; Zhu, H1
Avilés, A; Delgado, S; Díaz-Maqueo, JC; García, EL; Guzmán, R; Nambo, MJ1
Ager, S; Baglin, TP; Bass, G; Mahendra, P; Marcus, RE; Richards, EM1
Akutsu, M; Kano, Y; Suzuki, K; Tsunoda, S1
Björkholm, M; Gruber, A; Liliemark, E; Liliemark, J; Osby, E; Peterson, C; Sirzea, F; Söderhäll, S; Zhou, R1
Appelbaum, FR; Bensinger, WI; Brunvand, MW; Buckner, CD; Chauncey, T; Clift, RA; Demirer, T; Dorn, R; Fefer, A; Gooley, TA; Holmberg, LA; Lilleby, K; Martin, PL; Maziarz, RT; McSweeney, PA; Montgomery, P; Press, OW; Rowley, SD; Sanders, JE; Schiffman, K; Soll, E; Storb, R; Weaver, CH; Weiden, PL; Zuckerman, N1
Fielding, AK; Goldstone, AH; Jamieson, E; Linch, DC; Sullivan, AM; Watts, MJ1
Kizaki, H; Onishi, Y2
Hagel, E; Hering, M; Krieger, G; Zwicker, C1
Masaoka, T1
Berdel, WE; Hoppe, B; Knauf, WU; Koenigsmann, MP; Notter, M; Oberberg, D; Reufi, B; Thiel, E1
Bates, SE; Dickstein, B; Fojo, AT; Gamelin, E; Regis, J; Sandor, VA; Wilson, W; Zhan, Z1
Asaka, M; Hashino, S; Imamura, M; Kasai, M; Kobayashi, S; Sakurada, K; Tanaka, J1
Anderson, S; Haynes, AP; McQuaker, IG; Russell, NH; Stainer, C1
Fujita, M; Murata, M; Nagai, M; Ohmori, M; Takahara, J1
Brunet, S; Cancelas, JA; García, J; Madoz, P; Martínez, C; Martino, R; Sureda, A1
Joshi, B; Li, L; Tang, DG; Zhu, Z1
Okamoto, M1
Constine, LS; Hicks, DG; O'Keefe, R; Packman, CH; Rapoport, AP; Rosier, RN; Rowe, JM; Rubin, SJ1
Bairey, O; Blickstein, D; Epstein, O; Gabbay, U; Lahav, J; Prokocimer, M; Shaklai, M; Stark, P1
Colomer, R; Gómez, H1
Buckner, CD; Schwartzberg, L; Upton, S; Walker, C; Weaver, CH; Zhen, B1
Fehse, N; Gutensohn, K; Hassan, HT; Kröger, N; Krüger, W; Lölliger, C; Zander, AR; Zeller, W1
Bushell, M; Clemens, MJ; Morley, SJ1
Cavalli, F; Ghielmini, M; Sanna, P; Van den Bosch, S1
Korístek, Z; Mayer, J; Vásová, I; Vodvárka, P; Vorlícek, J1
Chowhan, N; Davis, R; Hentschel, P; Iliya, A; Madajewicz, S; Manzione, J; Meek, A; Roche, P; Roque, C; Shady, M; Tfayli, A1
Hatzl-Griesenhofer, M; Huber, H; Maschek, W; Pichler, R; Wahl, G; Wimmer, G1
Chemnitz, J; Diehl, V; Draube, A; Engert, A; Josting, A; Mapara, MY; Reiser, M; Scheid, C; Söhngen, D; Tesch, H; Wolf, J1
Arita, K; Harada, K; Ide, T; Kurisu, K; Sadatomo, T; Tahara, E; Tahara, H; Uozumi, T1
Brunet, S; Martino, R; Muñoz, L; Sierra, J; Subirà, M; Sureda, A1
Hunter, N; Meyn, RE; Mirkovic, N; Story, MD1
Devereux, S; Goldstone, AH; Ings, SJ; Leverett, D; Linch, DC; MacMillan, A; Watts, MJ1
Arber, DA; Bhatia, R; Bhatia, S; Forman, SJ; Fung, H; Kashyap, A; Krishnan, A; Molina, A; Nademanee, A; Niland, JC; O'Donnell, MR; Parker, PA; Slovak, ML; Sniecinski, I; Snyder, DS; Spielberger, R; Stein, A1
Greco, FA1
Diehl, V; Draube, A; Engert, A; Josting, A; Reiser, M; Rueffer, U; Söhngen, D; Tesch, H; Wickramanayake, PD; Wolf, J1
Heinz, R; Karlic, H; Mühlberger, H; Pavlova, B; Pfeilstöcker, M; Pittermann, E; Salamon, J; Strobl, H1
Altés, A; Briones, J; Brunet, S; Cabezudo, E; López, R; Madoz, P; Martinez, C; Martino, R; Muñoz, L; Perea, G; Salar, A; Santamaría, A; Sierra, J; Sureda, A1
Brugarolas, A; Calvo, JP; Gonzalez Manzano, R; Jimenez, MM; Lopez-Picazo, JM; Ordoñez Tres, JM1
Chemnitz, J; Diehl, V; Draube, A; Engert, A; Fuchs, M; Josting, A; Reiser, M; Scheid, C; Schultz, A; Söhngen, D; Winter, S1
Hatano, H; Hatano, N; Kajita, Y; Kinoshita, T; Takasu, S; Usui, T; Wakabayashi, T; Yoshida, J1
Klener, P; Procházka, B; Slabý, J; Trnený, M1
Guinness, ME; Kenney, JL; Lacy, J; Reiss, M1
Beauchemin, M; Bertrand, R; Droin, N; Solary, E1
Chan, JK; Cheung, MM; So, JC; Wong, KF1
Lim, MS; Lim, S; Lin, Z; Sapp, M; Viani, MA1
Aurlien, E; Holte, H; Jakobsen, E; Kvalheim, G; Kvaløy, S; Rusten, LS1
Angus, B; Carey, PJ; Conn, J; Culligan, D; Haynes, A; Iqbal, A; Jackson, GH; Lennard, AL; Leonard, RC; Lucraft, H; Proctor, SJ; Russel, N; Stark, A; Taylor, PR; Wood, K1
Cernilová, I; Doubek, M; Klabusay, M; Korístek, Z; Mayer, J; Navrátil, M; Petráková, K; Vásová, I; Vodvárka, P; Vorlícek, J1
Browne, PV; Daly, PA; Duggan, C; Enright, H; Gardiner, N; Kennedy, MJ; McCann, SR; O'Connell, N1
Beyer, J; Huhn, D; Kingreen, D; Kleiner, S; Reif, S; Siegert, W1
Brand, K; Buttgereit, P; Ebert, O; Märten, A; Renoth, S; Schakowski, F; Schmidt-Wolf, IG; Schöttker, B; Schroers, R; Ziske, C1
Bilgrami, SA; Bona, RD; Clive, J; Edwards, RL; Feingold, JM; Naqvi, B; Tutschka, PJ1
Croockewit, AJ; Fibbe, WE; Kingma, T; Uyl-de Groot, CA; van Agthoven, M; van Imhoff, GW; van Oers, MH; Vellenga, E; Verdonck, LF; Volkers, CP; Wijermans, PJ1
Grimm, J; Jaehde, U; Kingreen, D; Kloft, C; Reif, S; Schunack, W; Siegert, W1
Larsson, R; Liminga, G; Martinsson, P; Nygren, P1
Hosomi, Y; Shibuya, M1
Becherer, A; Dudczak, R; Greinix, HT; Jaeger, U; Kalhs, P; Karanikas, G; Kletter, K; Mitterbauer, M; Pötzi, C; Raderer, M1
Alessandrino, EP; Arcaini, L; Astori, C; Bernasconi, P; Brusamolino, E; Cairoli, R; Calatroni, S; Colombo, AA; Gargantini, L; Iacona, I; Lazzarino, M; Morra, E; Orlandi, E; Pagnucco, G; Regazzi, MB1
Fukuhara, S; Kanazawa, S; Kuwana, M; Nomura, S; Yamaguchi, K; Yoshimura, C1
Arai, T; Hanada, R; Ida, K; Inatomi, J; Kawaguchi, H; Kikuchi, A; Kishimoto, H; Oh-Ishi, T; Taketani, T; Yamamoto, K1
Aggarwal, S; Arora, A; Bhalla, S; Murthy, SA; Singh, B; Vohra, R1
Hagemeister, FB1
Campbell, AK; Chin, SF; Davies, S; Errington, RJ; Smith, PJ; Wiltshire, M1
Bunn, PA; Ihde, DC; Radice, PA1
Henney, JE; Muggia, FM; Rozencweig, M; Von Hoff, DD1
Crooke, ST; Issell, BF1
Arnold, AM1
Al-Sarraf, M; Cecil, JW; Coltman, CA; Groppe, CW; Quagliana, JM; Thigpen, T1
Barlogie, B; Drewinko, B1
Bonadonna, G; Bregni, M; Di Nicola, M; Gianni, AM; Lombardi, F; Magni, M; Pileri, A; Siena, S; Tarella, C1
Chabner, BA; Duffey, PL; Longo, DL; Urba, WJ; Wilson, WH; Wittes, R1
Hotta, T; Kiya, K; Kurisu, K; Mikami, T; Ogasawara, H; Sugiyama, K; Uozumi, T1
Ezaki, K; Hirano, M; Maruyama, F; Okamoto, M1
Ashihara, E; Fujita, N; Goto, H; Inaba, T; Ito, K; Murakami, S; Okawa, K; Oku, N; Shimazaki, C; Tsuji, H1
Bulova, SI; Ciobanu, N; Cooper, BW; Creger, RJ; Crilley, P; Fox, RM; Gucalp, R; Lazarus, HM; Shina, DC; Topolsky, D1
Bryant, G; Carter, C; Cottler-Fox, M; Cowan, KH; Goldspiel, B; Jain, V; Longo, DL; Steinberg, SM; Wilson, WH; Wittes, RE1
Fay, JW; Harden, EA; Herzig, GP; Herzig, RH; Heye, MM; Meagher, RC; Montes, VM; Stevens, DA1
Blume, KG; Forman, SJ1
Janmohammed, RM; Leyland, MJ; Long, SG; Macdonald, DF; Milligan, DW; Smith, AG1
Appelbaum, FR; Bensinger, WI; Buckner, CD; Clift, RA; Deeg, HJ; Petersen, FB; Sanders, JE; Storb, R; Sullivan, KM; Witherspoon, RP1
Rybka, WB1
Chang, SC; Hsu, JR; Perng, RP1
Anders, CH; Moritz, T; Nagel-Hiemke, M; Niederle, N; Nowrousian, MR; Schmidt, CG; Seeber, S1
Di Noto, R; Fabbiano, F; Gentile, S; Guarnaccia, C; Indovina, A; Majolino, I; Patti, C; Santoro, A; Scimè, R; Vasta, S1
Maca, RD1
Bertino, J; Crown, JP; Gulati, S; Heelan, R; Kolitz, J; Lee, BJ; O'Brien, J; Portlock, C; Straus, DJ1
Cabanillas, F2
Airo, I; Helve, O; Hiltunen, KM; Mattila, J1
Brashear, T; Fay, J; Miller, G; Stone, M1
Connors, JM; Klimo, P; O'Reilly, SE1
Brincker, H; Mirza, MR1
Frazier, SR; Greco, FA; Hainsworth, JD; Johnson, DH1
Creger, RJ; Fox, RM; Lazarus, HM1
Akiyama, Y; Ito, M; Kamiya, H; Kawa, K; Mikawa, H; Miyazaki, S; Sakurai, M; Tujino, G; Ueda, K1
Alberts, DS; Asbury, RF; Boros, L; Goodman, TL; Hickox, DE; Peng, YM; Penn, TE1
Pawlicki, M; Rachtan, J; Sliz, E1
Burns, LJ; Fyfe, MA; Ginder, GD; Gingrich, RD; Wen, BC1
Bolwell, BJ; Brown, RA; Frei-Lahr, D; Hande, KR; Harden, EA; Herzig, GP; Herzig, RH; Lowder, JN; Pineiro, L; Wolff, SN1
Gulati, SC; Lemoli, RM1
Bron, D; Stryckmans, P; Vandenheule, B1
Colvin, OM; Santos, GW1
Gaynor, E; Ultmann, JE; Watson, S; Williams, SF1
DeVita, VT1
Daly, PA; Finn, T; Lawlor, E; O'Briain, DS; O'Brien, AA; Rogers, FM; Ward, R1
Atzpodien, J; Clarkson, BD; Colvin, OM; Gulati, SC; Jain, K; Langleben, A; Ng, RP; Shimazaki, C; Yopp, J1
Douay, L1
Goto, S; Hotta, T; Ichikawa, A; Inoue, C; Murate, T; Nagura, E; Ninomiya, N; Ohnishi, K; Tsushita, K; Utsumi, M1
Bauer, H; Fehrentz, D; Hunstein, W; Keilholz, U; Körbling, M1
Hamada, H; Ishida, Y; Minato, K; Ohtsu, T; Shimoyama, M; Sugimoto, Y; Tobinai, K; Tsuruo, T1
DeVita, VT; Fisher, RI; Longo, D; Young, RC1
Jones, RJ; Santos, GW1
Cassileth, PA; Gale, RP; Stadtmauer, EA1
DeVita, VT; Duffey, PL; Fisher, RI; Gilliom, M; Glatstein, E; Hubbard, SM; Ihde, DC; Jaffe, ES; Longo, DL; Young, RC1
Alonso, MT; Leyland-Jones, B; Marsoni, S; O'Dwyer, PJ; Wittes, RE1
Kimura, K; Niitani, H; Yamada, K1
Cummings, J; Cunningham, D; Forrest, GJ; McTaggart, L; Soukop, M; Stuart, JF1
Cabanillas, F; Hagemeister, FB; Jagannath, S; McLaughlin, P; Redman, JR; Rodriguez, MA; Swan, F; Velasquez, WS1
Blaise, D; Gaspard, MH; Gastaut, JA; Maraninchi, D; Michel, G; Novakovitch, G; Rossi, JF; Stoppa, AM; Tubiana, N; Weiller, PJ1
Huijgens, PC; Ossenkoppele, GJ; Reijneke, RM; Thomas, LL; van der Lelie, J; Wijngaarden, MJ1
Pawlicki, M; Sliz, E; Zuchowska-Vogelgesang, B1
Greist, A; Hoffman, R; Kubilis, PS; Loehrer, PJ; Nichols, CR1
Horiuchi, A; Kanamaru, A; Kawagoe, H; Kitani, T; Kohsaki, M; Masaoka, T; Nagai, K; Shibata, H; Tagawa, S; Tsubaki, K1
Appelbaum, FR; Buckner, CD1
Lampkin, BC; Wong, KY1
Andreeff, M; Ciobanu, N; Paietta, E; Papenhausen, P; Wiernik, PH1
Grosh, WW; Hande, KR; Prater, K; Wolff, SN1
Carcassonne, Y; Finaud, M; Gastaut, JA; Horchowski, N; Lejeune, C; Sainty, D; Sebahoun, G; Tubiana, N1
Háber, J; Klener, P1
Fujii, H; Iwai, M; Kashiwadani, M; Maekawa, T; Miyoshi, M; Suyama, Y; Urata, Y1
Castro-Malaspina, H; Gulati, SC; Kushner, BH; Kwon, JH1
Atkins, C; Coonley, CJ; Danieu, L; Warrell, RP1
Cabanillas, F; Fuller, L; Hagemeister, FB; McLaughlin, P; Riggs, S; Smith, T; Velasquez, WS1
Abe, T; Kariyone, S; Maekawa, I; Maekawa, T; Miura, A; Miura, Y; Moriyama, Y; Shibata, A; Wakui, A; Yoshida, Y1
Ogawa, M1
Crowther, D; Gasser, AB; Scarffe, JH; Steward, WP; Wagstaff, J1
Dent, DM; Hayes, M; Jacobs, P; King, HS1
Cavallin-Ståhl, E; Hagberg, H; Lind, J1
Kimura, K; Yamada, K; Yoshida, T1
Arakawa, S; Esumi, N; Imashuku, S; Todo, S1
Ito, K; Kobayashi, K; Matsuda, T; Nakagoshi, T; Nakamura, E; Nakamura, S; Nakanishi, J; Natori, K; Ohtake, S; Yoshida, T1
Aisner, J; Egorin, MJ; Jones, JM; Olman, EA1
Hancock, BW1
Cavalli, F1
Horiuchi, A; Kanamaru, A; Kawagoe, H; Kitani, T; Kohsaki, M; Konishi, I; Masaoka, T; Nagai, K; Shibata, H; Tsubaki, K1
Judson, IR; Wiltshaw, E1
Hiraki, S; Kimura, I; Miyamoto, H; Murashima, M; Ohnoshi, T; Toyata, K; Ueno, K; Ueoka, H; Yamane, T1

Reviews

27 review(s) available for etoposide and Lymphoma

ArticleYear
Focus on lymphomas.
    Cancer cell, 2002, Volume: 2, Issue:5

    Topics: Alemtuzumab; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Etoposide; Gene Expression; Humans; Interleukin-2; Lymphoma; Prednisone; Risk Factors; Rituximab; Survival; Vaccines; Vincristine

2002
[Chemotherapy for brain tumor].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 9

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Drug Delivery Systems; Etoposide; Humans; Lymphoma; Medulloblastoma; Methotrexate; Neoplasms, Germ Cell and Embryonal; Nimustine; Oligodendroglioma; Platinum Compounds; Randomized Controlled Trials as Topic; Vincristine

2005
The hematologic malignancies. Leukemia, lymphoma, and myeloma.
    Cancer, 1984, Dec-01, Volume: 54, Issue:11 Suppl

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Interferons; Leukemia; Lymphoma; Mechlorethamine; Multiple Myeloma; Prednisone; Procarbazine; Prognosis; Translocation, Genetic; Vincristine

1984
[Malignant lymphoma].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1994, Mar-10, Volume: 83, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Vincristine

1994
Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation.
    Bone marrow transplantation, 1994, Volume: 14 Suppl 4

    Topics: Actuarial Analysis; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cyclophosphamide; Etoposide; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome; Whole-Body Irradiation

1994
Etoposide: current status and future perspectives in the management of malignant neoplasms.
    Cancer chemotherapy and pharmacology, 1994, Volume: 34 Suppl

    Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Etoposide; Germinoma; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Neoplasms; Sarcoma, Kaposi; Stomach Neoplasms

1994
Teniposide: overview of its therapeutic potential in adult cancers.
    Cancer chemotherapy and pharmacology, 1994, Volume: 34 Suppl

    Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Etoposide; Female; Genital Neoplasms, Female; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Sarcoma, Kaposi; Teniposide

1994
Etoposide dosage and pharmacodynamics.
    Cancer chemotherapy and pharmacology, 1994, Volume: 34 Suppl

    Topics: Carcinoma, Small Cell; Clinical Trials, Phase I as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Humans; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Lung Neoplasms; Lymphoma

1994
[Etoposide 21 therapy for malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:14

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Leukopenia; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multicenter Studies as Topic; Nausea; Palliative Care

1996
[Treatment of lymphoma in the aged].
    Medicina clinica, 1998, May-02, Volume: 110, Issue:15

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Palliative Care; Prednimustine; Prednisolone; Prednisone; Prognosis; Vincristine

1998
Oral etoposide in lymphoma.
    Drugs, 1999, Volume: 58 Suppl 3

    Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Etoposide; Humans; Lymphoma

1999
[Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:10

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase II as Topic; Cytarabine; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymphoma; Mesna; Methylprednisolone; Mitoxantrone

2001
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Cancer chemotherapy and pharmacology, 2002, Volume: 49 Suppl 1

    Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma; Middle Aged; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Vincristine

2002
VM 26 and VP 16-213: a comparative analysis.
    Cancer, 1977, Volume: 40, Issue:1

    Topics: Animals; Brain Neoplasms; Drug Evaluation; Etoposide; Humans; Kinetics; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms, Experimental; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms

1977
Etoposide (VP-16-213).
    Cancer treatment reviews, 1979, Volume: 6, Issue:2

    Topics: Adult; Animals; Bone Marrow; Cell Cycle; Child; Digestive System; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia; Lung Neoplasms; Lymphoma; Male; Mice; Neoplasms; Neoplasms, Experimental; Podophyllotoxin; Rats

1979
Podophyllotoxin derivative VP 16-213.
    Cancer chemotherapy and pharmacology, 1979, Volume: 3, Issue:2

    Topics: Animals; Bronchial Neoplasms; Carcinoma; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; In Vitro Techniques; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Lymphoma; Mice; Neoplasms; Podophyllotoxin; Rabbits; Rats; Sarcoma

1979
Recent National Cancer Institute lymphoma trials of etoposide-containing combination chemotherapy.
    Seminars in oncology, 1992, Volume: 19, Issue:6 Suppl 13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma; Methotrexate; National Institutes of Health (U.S.); Prednisone; United States; Vincristine

1992
High-dose etoposide (VP-16)-containing preparatory regimens in allogeneic and autologous bone marrow transplantation for hematologic malignancies.
    Seminars in oncology, 1992, Volume: 19, Issue:6 Suppl 13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chemotherapy, Adjuvant; Etoposide; Humans; Leukemia; Lymphoma; Multiple Myeloma; Whole-Body Irradiation

1992
The evolving role of etoposide in the management of lymphomas and Hodgkin's disease.
    Cancer, 1991, Jan-01, Volume: 67, Issue:1 Suppl

    Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin

1991
[Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
    Revue medicale de Bruxelles, 1985, Volume: 6, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Vincristine

1985
Pharmacological purging of bone marrow with reference to autografting.
    Clinics in haematology, 1986, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Animals; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Cell Separation; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lysophosphatidylcholines; Methylprednisolone; Neoplasms, Experimental; Phospholipid Ethers; Pyrimidinones; Transplantation, Autologous; Transplantation, Isogeneic

1986
Pharmacological bone marrow purging with drugs other than cyclophosphamide derivatives.
    Bone marrow transplantation, 1989, Volume: 4 Suppl 1

    Topics: Animals; Antineoplastic Agents; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Etoposide; Humans; Leukemia; Lymphoma; Mice; Mice, Inbred C57BL; Neoplastic Stem Cells; Preoperative Care

1989
Experience with ifosfamide combinations in malignant lymphomas.
    Seminars in oncology, 1989, Volume: 16, Issue:1 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Mitoguazone

1989
Etoposide in leukemia, lymphoma and bone marrow transplantation.
    Leukemia research, 1989, Volume: 13, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Etoposide; Humans; Leukemia; Lymphoma

1989
Etoposide (VP-16-213). Current status of an active anticancer drug.
    The New England journal of medicine, 1985, Mar-14, Volume: 312, Issue:11

    Topics: Animals; Carcinoma, Small Cell; Clinical Trials as Topic; DNA; Drug Administration Schedule; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Male; Mice; Podophyllotoxin; Testicular Neoplasms; Tissue Distribution

1985
Overview of the clinical relevance of autologous bone marrow transplantation.
    Clinics in haematology, 1986, Volume: 15, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Evaluation; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Neoplasm Recurrence, Local; Neoplasms; Thioguanine; Transplantation, Autologous

1986
Indications for and benefits of intensive therapies in treatment of childhood cancers.
    Cancer, 1986, Jul-15, Volume: 58, Issue:2 Suppl

    Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Etoposide; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Methotrexate; Neoplasms; Osteosarcoma; Risk; Sarcoma, Ewing

1986

Trials

108 trial(s) available for etoposide and Lymphoma

ArticleYear
Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin's Lymphoma: A Mul
    Cancer research and treatment, 2023, Volume: 55, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Behavior Therapy; Busulfan; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Transplantation, Autologous

2023
Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study.
    Leukemia & lymphoma, 2022, Volume: 63, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carboplatin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Lymphoma; Neoplasm Recurrence, Local; Treatment Outcome

2022
Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years.
    Journal of cancer research and clinical oncology, 2022, Volume: 148, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Etoposide; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy

2022
LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma.
    Bone marrow transplantation, 2019, Volume: 54, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Male; Methotrexate; Prednisolone; Prospective Studies; Transplantation Conditioning; Transplantation, Autologous

2019
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas.
    Blood advances, 2018, 12-26, Volume: 2, Issue:24

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; APOBEC-3G Deaminase; Bortezomib; Carboplatin; Etoposide; Female; HIV; HIV Infections; Humans; Ifosfamide; Leukocytes, Mononuclear; Lymphoma; Male; Middle Aged; Oncolytic Virotherapy; Recurrence; Rituximab; Viral Load

2018
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:7

    Topics: Adult; Aged; Busulfan; Carmustine; Cyclophosphamide; Cytarabine; Drug Combinations; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Middle Aged; North America; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous

2016
A randomized, double-blind trial of pegfilgrastim versus filgrastim for the management of neutropenia during CHASE(R) chemotherapy for malignant lymphoma.
    British journal of haematology, 2016, Volume: 174, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Management; Double-Blind Method; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Rituximab; Young Adult

2016
Phase II Study of Propylene Glycol-Free Melphalan Combined with Carmustine, Etoposide, and Cytarabine for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:12

    Topics: Adolescent; Adult; Aged; Carmustine; Cytarabine; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Myeloablative Agonists; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult

2016
Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial.
    Bone marrow transplantation, 2009, Volume: 43, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Double-Blind Method; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Mouthwashes; Phytohemagglutinins; Pilot Projects; Placebos; Recombinant Proteins; Stomatitis

2009
Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study.
    Bone marrow transplantation, 2010, Volume: 45, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Feasibility Studies; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Kinetics; Lymphoma; Male; Melphalan; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult

2010
Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:4

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Societies, Medical; Time Factors; Vincristine; Young Adult

2010
Feasibility of BU, CY and etoposide (BUCYE), and auto-SCT in patients with newly diagnosed primary CNS lymphoma: a single-center experience.
    Bone marrow transplantation, 2011, Volume: 46, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Recurrence; Remission Induction; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous

2011
A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:7

    Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Carmustine; Combined Modality Therapy; Cytarabine; Cytoprotection; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lymphoma; Male; Maximum Tolerated Dose; Melphalan; Middle Aged; Mucositis; Pancytopenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Transplantation Conditioning; Transplantation, Autologous; Young Adult

2011
Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Feb-15, Volume: 18, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Consolidation Chemotherapy; Cytarabine; Dacarbazine; Diffusion Magnetic Resonance Imaging; Etoposide; Female; Humans; Immunotherapy; Lymphoma; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Rituximab; Survival Analysis; Temozolomide; Treatment Outcome

2012
A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma.
    British journal of haematology, 2013, Volume: 161, Issue:2

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Synergism; Etoposide; Female; Humans; Hydroxamic Acids; Ifosfamide; Lymphoma; Male; Middle Aged; Rituximab; Vorinostat

2013
A phase I dose-escalation study of etoposide continuous infusion added to busulphan/cyclophosphamide as conditioning prior to autologous or allogeneic stem cell transplantation.
    Bone marrow transplantation, 2002, Volume: 30, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Lymphoma; Male; Maximum Tolerated Dose; Middle Aged; Mucous Membrane; Stomatitis; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous

2002
Mitoxantrone/ifosfamide/etoposide salvage regimen with rituximab for in vivo purging in patients with relapsed lymphoma.
    Clinical lymphoma, 2002, Volume: 3, Issue:2

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mesna; Middle Aged; Mitoxantrone; Polymerase Chain Reaction; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Stem Cells; Time Factors

2002
Comparative pharmacokinetic study of high-dose etoposide and etoposide phosphate in patients with lymphoid malignancy receiving autologous stem cell transplantation.
    Bone marrow transplantation, 2003, Volume: 31, Issue:8

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Chromatography, High Pressure Liquid; Etoposide; Hodgkin Disease; Humans; Life Expectancy; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Middle Aged; Multiple Myeloma; Organophosphorus Compounds; Stem Cell Transplantation; Time Factors; Transplantation, Autologous

2003
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma.
    Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:6

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cyclophosphamide; Epirubicin; Etoposide; Female; Hepatitis B; Hepatitis B virus; Humans; Lymphoma; Male; Middle Aged; Prednisolone; Risk Factors; Survival Analysis; Treatment Outcome; Virus Activation

2003
Pilot phase I/II study of new salvage therapy (CHASE) for refractory or relapsed malignant lymphoma.
    International journal of hematology, 2003, Volume: 77, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Remission Induction; Salvage Therapy; Survival Rate; Transplantation, Autologous; Treatment Outcome

2003
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation.
    Bone marrow transplantation, 2004, Volume: 34, Issue:1

    Topics: Adolescent; Adult; Aged; Breast Neoplasms; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Incidence; Leukemia; Lymphoma; Male; Middle Aged; Neoplasms, Second Primary; Neural Tube Defects; Peripheral Blood Stem Cell Transplantation; Probability; Transplantation, Autologous

2004
High-dose treosulfan in patients with relapsed or refractory high-grade lymphoma receiving tandem autologous blood stem cell transplantation.
    Bone marrow transplantation, 2004, Volume: 34, Issue:6

    Topics: Adult; Antineoplastic Agents, Alkylating; Busulfan; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma; Male; Middle Aged; Recurrence; Stem Cell Transplantation; Transplantation, Autologous

2004
ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience.
    European journal of haematology, 2004, Volume: 73, Issue:3

    Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Leukapheresis; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Scandinavian and Nordic Countries; Treatment Outcome

2004
Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study.
    Bone marrow transplantation, 2004, Volume: 34, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Cytarabine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Male; Melphalan; Middle Aged; Multivariate Analysis; Retrospective Studies; Time Factors; Transplantation Conditioning; Transplantation, Autologous

2004
Glomerular dysfunction, independent of tubular dysfunction, induced by antineoplastic chemotherapy in children.
    Pediatrics international : official journal of the Japan Pediatric Society, 2004, Volume: 46, Issue:5

    Topics: Acute Disease; Adolescent; Albuminuria; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Creatinine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Glomerular Filtration Rate; Humans; Kidney Tubules; Leukemia; Lymphoma; Methotrexate; Neoplasms; Neuroblastoma; Osteosarcoma; Proteinuria; Rhabdomyosarcoma; Vincristine

2004
Long-term results of dose density therapy in patients with aggressive lymphoma.
    Annals of hematology, 2005, Volume: 84, Issue:4

    Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Humans; Ifosfamide; Longitudinal Studies; Lymphoma; Mesna; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Treatment Failure; Treatment Outcome; Vincristine

2005
Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study.
    British journal of haematology, 2005, Volume: 128, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Interleukin-11; Lymphoma; Male; Neoplasms; Platelet Count; Recombinant Proteins; Thrombocytopenia

2005
A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with relapsed and refractory lymphoma.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Remission Induction; Salvage Therapy; Survival Analysis

2005
Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary report.
    Seminars in oncology, 2004, Volume: 31, Issue:6 Suppl 18

    Topics: Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Cytoprotection; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Middle Aged; Radiation-Protective Agents; Transplantation, Autologous

2004
[An early phase II clinical study of YM 294 (rhlL-11) in patients with solid tumors and malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Edema; Etoposide; Female; Fever; Humans; Interleukin-11; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Platelet Count; Recombinant Proteins; Thrombocytopenia

2005
First-line autologous stem cell transplantation in primary CNS lymphoma.
    European journal of haematology, 2005, Volume: 75, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompetence; Lymphoma; Male; Melphalan; Middle Aged; Neurotoxicity Syndromes; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Survival Rate; Transplantation, Autologous

2005
Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with po
    Cancer, 2006, Jan-01, Volume: 106, Issue:1

    Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Prospective Studies; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vincristine

2006
Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma.
    Annals of hematology, 2006, Volume: 85, Issue:6

    Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Prognosis; Remission Induction; Treatment Outcome; Vincristine

2006
Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation.
    Experimental hematology, 2006, Volume: 34, Issue:3

    Topics: Antineoplastic Agents; Cyclophosphamide; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Multiple Myeloma; Polyethylene Glycols; Recombinant Proteins; Transplantation, Autologous

2006
Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma.
    Transfusion, 2006, Volume: 46, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Polyethylene Glycols; Recombinant Proteins; Remission Induction; Transplantation, Autologous; Treatment Outcome

2006
High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
    Bone marrow transplantation, 2006, Volume: 38, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Remission Induction; Stem Cell Transplantation; Transplantation, Autologous

2006
High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma.
    Leukemia & lymphoma, 2006, Volume: 47, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma; Male; Maximum Tolerated Dose; Melphalan; Middle Aged; Mitoxantrone; Peripheral Blood Stem Cell Transplantation; Prognosis; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation, Autologous

2006
Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma.
    Leukemia & lymphoma, 2006, Volume: 47, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Paclitaxel; Recurrence; Stem Cells; Time Factors; Vinblastine; Vinorelbine

2006
Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
    Cancer, 2007, Feb-15, Volume: 109, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Carboplatin; Cyclophosphamide; Etoposide; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Lymphoma; Male; Methotrexate; Middle Aged; Osmosis; Ovarian Neoplasms; Prospective Studies; Survival Rate

2007
Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    European journal of haematology, 2007, Volume: 78, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gastrointestinal Diseases; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Salvage Therapy; Sepsis; Survival Rate; Transplantation, Autologous; Treatment Outcome

2007
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation.
    Bone marrow transplantation, 2007, Volume: 39, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lymphoma; Male; Melphalan; Remission Induction; Transplantation Conditioning; Transplantation, Homologous

2007
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neurotoxicity Syndromes; Prednisone; Procarbazine; Retrospective Studies; Salvage Therapy; Survival Analysis; Vincristine

2007
Intermediate dose etoposide plus G-CSF 16 g/kg is more effective than cyclophosphamide 4 g/m(2) plus G-CSF 10 g/kg in PBSC mobilization of lymphoma patients.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:10

    Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Immunosuppressive Agents; Leukapheresis; Lymphoma; Male; Middle Aged; Outpatients; Stem Cell Transplantation; Stem Cells; Treatment Outcome

2007
Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.
    Cancer, 2008, May-15, Volume: 112, Issue:10

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Humans; Lymphoma; Lymphoma, Mantle-Cell; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Survival Rate; Time Factors

2008
VP-16-213 (etoposide): the mandrake root from Issyk-Kul.
    The American journal of medicine, 1982, Volume: 72, Issue:1

    Topics: Animals; Breast Neoplasms; Carcinoma, Small Cell; Cell Cycle; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dysgerminoma; Etoposide; Female; Humans; Leukemia; Lung Neoplasms; Lymphoma; Mice; Podophyllotoxin

1982
[New antineoplastic drugs of the podophyllotoxin derivative group].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1983, Jan-03, Volume: 38, Issue:1

    Topics: Adult; Child; Clinical Trials as Topic; Etoposide; Female; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms

1983
[Phase II study of etoposide (NK 171) in advanced hematological malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:8

    Topics: Administration, Oral; Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Leukemia; Leukopenia; Lymphoma; Male; Middle Aged; Nausea; Podophyllotoxin; Prednisolone; Thrombocytosis; Vincristine

1984
Cis-dichlorodiammineplatinum (II), VP 16-213, and prednisone (DVP regimen) in the treatment of pretreated advanced malignant lymphomas.
    Tumori, 1982, Dec-31, Volume: 68, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Drug Therapy, Combination; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Podophyllotoxin; Prednisone

1982
A prospective randomized study of adjuvant parenteral nutrition in the treatment of diffuse lymphoma: effect on drug tolerance.
    Cancer treatment reports, 1981, Volume: 65 Suppl 5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Etoposide; Humans; Leucovorin; Leukocyte Count; Lymphoma; Mechlorethamine; Methotrexate; Nutrition Disorders; Parenteral Nutrition; Platelet Count; Prednisone; Procarbazine; Prospective Studies; Random Allocation; Serum Albumin; Vincristine

1981
Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Lymphoma; Male; Middle Aged; Neutropenia; Neutrophils; Prospective Studies; Recombinant Proteins; Survival Rate; Transplantation, Autologous

1994
[Peripheral blood stem cell collection with high dose etoposide].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:3

    Topics: Adult; Aged; Blood Component Removal; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1995
Prolonged daily administration of oral etoposide in lymphoma following prior therapy with adriamycin, an ifosfamide-containing salvage combination, and intravenous etoposide.
    Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Palliative Care; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia

1995
Peripheral blood stem cell mobilization with chemotherapy and granulocyte-colony stimulating factor in patients with hematological malignancies.
    The Tokai journal of experimental and clinical medicine, 1994, Volume: 19, Issue:3-6

    Topics: Adolescent; Adult; Antigens, CD34; Colony-Forming Units Assay; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged

1994
Expression of mdr-1 in refractory lymphoma: quantitation by polymerase chain reaction and validation of the assay.
    Blood, 1995, Aug-15, Volume: 86, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta 2-Microglobulin; Cyclophosphamide; Doxorubicin; Drug Resistance, Multiple; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Immunophenotyping; Lymphoma; Polymerase Chain Reaction; Prednisone; RNA, Messenger; RNA, Neoplasm; Time Factors; Vincristine

1995
Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Cyclophosphamide; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Hypotension; Leukocyte Count; Lymphoma; Male; Middle Aged; Neutrophils; Platelet Count; Prednisone; Sarcoma; Stereoisomerism; Verapamil; Vincristine

1995
Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Over Studies; Cyclophosphamide; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Polymerase Chain Reaction; Prednisone; Remission Induction; Stereoisomerism; Verapamil; Vincristine

1995
Therapeutic strategies in intermediate grade lymphomas in elderly patients. The Italian Multiregional non Hodgkin's Lymphoma Study Group (IMRNHLSG).
    Hematological oncology, 1993, Volume: 11 Suppl 1

    Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Prednisone; Recombinant Proteins; Survival Analysis; Time Factors; Vinblastine

1993
Bone marrow purging with etoposide/methylprednisolone in patients undergoing autologous bone marrow transplantation.
    Progress in clinical and biological research, 1994, Volume: 389

    Topics: Adolescent; Adult; Aged; Bone Marrow Purging; Bone Marrow Transplantation; Child; Etoposide; Humans; Leukemia; Leukocyte Count; Lymphoma; Methylprednisolone; Middle Aged; Neutrophils; Platelet Count; Transplantation, Autologous

1994
Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation.
    Bone marrow transplantation, 1994, Volume: 14 Suppl 4

    Topics: Actuarial Analysis; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cyclophosphamide; Etoposide; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome; Whole-Body Irradiation

1994
Phase I clinical and pharmacokinetic study of oral etoposide phosphate.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:1

    Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Biological Availability; Drug Administration Schedule; Etoposide; Humans; Injections, Intravenous; Lymphoma; Middle Aged; Models, Biological; Neoplasms; Neutropenia; Organophosphorus Compounds; Prodrugs

1995
A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma.
    Cancer, 1995, Mar-15, Volume: 75, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lung Diseases, Interstitial; Lymphoma; Middle Aged; Transplantation, Autologous; Treatment Outcome

1995
High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Transplantation, Homologous

1995
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas.
    Investigational new drugs, 1994, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Mesna; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisone; Salvage Therapy

1994
Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Hypocalcemia; Hypotension; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Remission Induction; Transplantation, Autologous

1994
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Prognosis; Recurrence; Remission Induction; Survival Rate

1994
Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Mitoxantrone

1994
Interleukin-3 enhances the endogenous leukotriene production.
    Blood, 1993, May-01, Volume: 81, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Humans; Ifosfamide; Interleukin-3; Leukocyte Count; Leukotriene B4; Leukotrienes; Lymphoma; Recombinant Proteins

1993
[Study on the inhibitory effect of oral granisetron against nausea/vomiting induced by cytosine arabinoside containing chemotherapy for tumors in the hematopoietic organs].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:10

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Granisetron; Humans; Indazoles; Lymphoma; Male; Middle Aged; Mitoxantrone; Nausea; Vomiting

1993
A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Mesna; Middle Aged; Mitoxantrone; Platinum; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Treatment Failure

1995
Dose intensification of etoposide in the BEAM ABMT protocol for malignant lymphoma.
    Leukemia & lymphoma, 1995, Volume: 17, Issue:3-4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Male; Melphalan; Middle Aged

1995
Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.
    Neurosurgery, 1995, Volume: 37, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Child; Etoposide; Female; Germinoma; Glioblastoma; Humans; Lymphoma; Male; Middle Aged; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Tomography, X-Ray Computed

1995
Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF.
    Bone marrow transplantation, 1996, Volume: 17, Issue:2

    Topics: Adult; Bone Marrow; Breast Neoplasms; Busulfan; Carboplatin; Carmustine; Cyclophosphamide; Drug Administration Schedule; Drug Synergism; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Interleukin-3; Leukapheresis; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged; Neutrophils; Prospective Studies; Thiotepa; Whole-Body Irradiation

1996
[Clinical trial of oral etoposide in the treatment of malignancies].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1995, Volume: 17, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Child; Etoposide; Female; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Ovarian Neoplasms; Prospective Studies

1995
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.
    Bone marrow transplantation, 1996, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Graft Survival; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Humans; Life Tables; Lymphoma; Male; Middle Aged; Prospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation

1996
Peripheral blood progenitor cell mobilization with Dexa-Beam/G-CSF, ether lipid purging, and autologous transplantation after high-dose CBV treatment: a safe and effective regimen in patients with poor risk malignant lymphomas.
    Leukemia & lymphoma, 1996, Volume: 23, Issue:3-4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cell Movement; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Lymphoma; Melphalan; Middle Aged; Phospholipid Ethers; Risk Factors; Transplantation Conditioning

1996
Efficient peripheral blood stem cell mobilization with low-dose G-CSF (50 microg/m2) after salvage chemotherapy for lymphoma.
    Bone marrow transplantation, 1997, Volume: 20, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Leukocyte Count; Lymphoma; Male; Middle Aged; Recombinant Proteins; Salvage Therapy

1997
[Long-term follow up of aggressive lymphoma patients treated with CAMBO-VIP--clinical significance of a residual mass after otherwise successful chemotherapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Time Factors; Vincristine

1998
A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy.
    American journal of clinical oncology, 1998, Volume: 21, Issue:4

    Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Survival Analysis

1998
Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization.
    Bone marrow transplantation, 1999, Volume: 23, Issue:12

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Recurrence; Transplantation Conditioning

1999
Telomerase activity in central nervous system malignant lymphoma.
    Cancer, 1999, Sep-15, Volume: 86, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Catalytic Domain; Combined Modality Therapy; DNA-Binding Proteins; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Prednisolone; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA; Survival Analysis; Telomerase; Vincristine

1999
ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients.
    British journal of cancer, 2000, Volume: 82, Issue:2

    Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Matched-Pair Analysis; Methylprednisolone

2000
Dexamethasone, carmustine, etoposide, cytarabine, and melphalan (dexa-BEAM) followed by high-dose chemotherapy and stem cell rescue--a highly effective regimen for patients with refractory or relapsed indolent lymphoma.
    Leukemia & lymphoma, 2000, Volume: 37, Issue:1-2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous

2000
[Effectiveness of DeVIC chemotherapy for recurrent primary central nervous system lymphoma].
    No shinkei geka. Neurological surgery, 2000, Volume: 28, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Treatment Outcome

2000
Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Neoplasma, 2000, Volume: 47, Issue:5

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Indoles; Lymphoma; Male; Melphalan; Nausea; Ondansetron; Serotonin Antagonists; Transplantation, Autologous; Tropisetron; Vomiting

2000
Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients.
    European journal of haematology. Supplementum, 2001, Volume: 64

    Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Etoposide; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma; Methotrexate; Middle Aged; Mitoguazone; Premedication; Recurrence; Transplantation, Autologous

2001
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    European journal of haematology. Supplementum, 2001, Volume: 64

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Recurrence; Salvage Therapy; Survival Rate; Treatment Outcome

2001
Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.
    European journal of haematology. Supplementum, 2001, Volume: 64

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kinetics; Lymphoma; Male; Mesna; Methotrexate; Middle Aged; Mitoxantrone; Prognosis; Salvage Therapy; Treatment Outcome

2001
Effective progenitor cell mobilization in lymphoproliferative disorders using ifosfamide, epirubicin and etoposide (IEV).
    European journal of haematology. Supplementum, 2001, Volume: 64

    Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukapheresis; Lymphoma; Lymphoproliferative Disorders; Male; Middle Aged; Salvage Therapy; Transplantation, Autologous; Treatment Outcome

2001
Cytoreduction and stem cell mobilization with a regimen of paclitaxel, etoposide and cyclophosphamide followed by autologous transplantation using a preparative regimen of busulfan, etoposide and cyclophosphamide for patients with advanced lymphoma.
    Acta haematologica, 2001, Volume: 105, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Paclitaxel; Salvage Therapy; Survival Analysis; Transplantation, Autologous

2001
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study.
    British journal of haematology, 2001, Volume: 114, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chi-Square Distribution; Cisplatin; Cost-Benefit Analysis; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prospective Studies; Quality of Life; Recurrence; Statistics, Nonparametric; Survival Rate; Transplantation, Autologous

2001
Bioequivalence investigation of high-dose etoposide and etoposide phosphate in lymphoma patients.
    Cancer chemotherapy and pharmacology, 2001, Volume: 48, Issue:2

    Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cross-Over Studies; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Lymphoma; Middle Aged; Organophosphorus Compounds; Prodrugs; Therapeutic Equivalency

2001
Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
    Cancer treatment reports, 1979, Volume: 63, Issue:8

    Topics: Alopecia; Carcinoma, Small Cell; Clinical Trials as Topic; Drug Evaluation; Etoposide; Humans; Leukemia; Leukopenia; Lung Neoplasms; Lymphoma; Podophyllotoxin; Teniposide

1979
Podophyllotoxin derivative VP 16-213.
    Cancer chemotherapy and pharmacology, 1979, Volume: 3, Issue:2

    Topics: Animals; Bronchial Neoplasms; Carcinoma; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; In Vitro Techniques; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Lymphoma; Mice; Neoplasms; Podophyllotoxin; Rabbits; Rats; Sarcoma

1979
High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lymphoma; Middle Aged; Recurrence; Survival Analysis; Transplantation, Autologous; Treatment Outcome

1992
Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Neoplasms; Survival Analysis; Transplantation, Autologous

1992
BEAM autografting in lymphoma--experience at one centre.
    Leukemia & lymphoma, 1992, Volume: 7 Suppl

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Lymphoma; Male; Melphalan; Middle Aged; Survival Rate; Transplantation, Autologous

1992
Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
    Bone marrow transplantation, 1992, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Cyclophosphamide; Etoposide; Graft vs Host Disease; Humans; Leukemia; Lymphoma; Middle Aged; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation

1992
Treatment of malignant lymphomas with very-high-dose CVB followed by transplantation of autologous blood stem cells collected after mobilizing chemotherapy.
    Haematologica, 1991, Volume: 76 Suppl 1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Lymphoma; Middle Aged; Pancytopenia; Pulmonary Fibrosis; Radiotherapy; Remission Induction; Transplantation, Autologous; Vindesine

1991
Mitoxantrone, etoposide, mitoguazone and vinblastine chemotherapy (MV2) in relapsed and refractory lymphomas.
    Investigational new drugs, 1991, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Etoposide; Hodgkin Disease; Humans; Lymphoma; Middle Aged; Mitoguazone; Mitoxantrone; Prognosis; Prospective Studies; Recurrence; Remission Induction; Vinblastine

1991
MIME combination chemotherapy in recurrent or refractory lymphoproliferative malignancies. A phase II study.
    Acta oncologica (Stockholm, Sweden), 1991, Volume: 30, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Mitoguazone; Prognosis

1991
Treatment of pediatric malignant tumors with VP-16. West Japan Pediatric Oncology Group.
    Acta paediatrica Japonica : Overseas edition, 1990, Volume: 32, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Histiocytosis; Humans; Infant; Leukemia, Myeloid, Acute; Lymphoma; Neoplasms; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1990
Pharmacological purging of bone marrow with reference to autografting.
    Clinics in haematology, 1986, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Animals; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Cell Separation; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lysophosphatidylcholines; Methylprednisolone; Neoplasms, Experimental; Phospholipid Ethers; Pyrimidinones; Transplantation, Autologous; Transplantation, Isogeneic

1986
Etoposide (VP-16-213). Current status of an active anticancer drug.
    The New England journal of medicine, 1985, Mar-14, Volume: 312, Issue:11

    Topics: Animals; Carcinoma, Small Cell; Clinical Trials as Topic; DNA; Drug Administration Schedule; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Male; Mice; Podophyllotoxin; Testicular Neoplasms; Tissue Distribution

1985
[Phase I clinical study of NK 171 (etoposide)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:4

    Topics: Administration, Oral; Adult; Aged; Carcinoma, Hepatocellular; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Podophyllotoxin

1985
[Evaluation of the effectiveness of Vepeside (VP-16-213) in the treatment of drug-resistant recurrences of malignant lymphatic neoplasms].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1987, May-15, Volume: 40, Issue:10

    Topics: Adult; Aged; Clinical Trials as Topic; Drug Resistance; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Recurrence

1987
Overview of the clinical relevance of autologous bone marrow transplantation.
    Clinics in haematology, 1986, Volume: 15, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Evaluation; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Neoplasm Recurrence, Local; Neoplasms; Thioguanine; Transplantation, Autologous

1986
Treatment of relapsed non-Hodgkin's lymphoma with a combination of hydroxyurea, ifosfamide, and etoposide.
    Cancer treatment reports, 1985, Volume: 69, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Etoposide; Female; Humans; Hydroxyurea; Ifosfamide; Lymphoma; Male; Middle Aged; Recurrence

1985
VP-16-213 in the treatment of stage III and IV diffuse large cell lymphoma.
    Cancer, 1985, Sep-01, Volume: 56, Issue:5

    Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Podophyllotoxin; Prognosis; Prospective Studies; Random Allocation

1985

Other Studies

284 other study(ies) available for etoposide and Lymphoma

ArticleYear
Synthesis of novel alkyltriazole tagged pyrido[2,3-d]pyrimidine derivatives and their anticancer activity.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:8

    Topics: Alkylation; Antineoplastic Agents; Azides; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Cyclization; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Leukemia, Monocytic, Acute; Lymphoma; Pyrimidines; Structure-Activity Relationship; Triazoles

2011
High D-index during mobilization predicts poor mobilization of CD34+ cells after anti-lymphoma salvage chemotherapy.
    Journal of clinical apheresis, 2022, Volume: 37, Issue:1

    Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Salvage Therapy; Severity of Illness Index; Young Adult

2022
Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis.
    Cancer biology & therapy, 2021, 12-02, Volume: 22, Issue:10-12

    Topics: Epstein-Barr Virus Infections; Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Retrospective Studies

2021
Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients.
    Bone marrow transplantation, 2022, Volume: 57, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Neoplasm Recurrence, Local; Transplantation Conditioning; Transplantation, Autologous

2022
Neutrophil decline rate following autologous transplant for lymphoma is a predictor of patients' outcome.
    Leukemia & lymphoma, 2022, Volume: 63, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Autografts; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Neoplasm Recurrence, Local; Neutrophils; Prospective Studies; Transplantation Conditioning; Transplantation, Autologous

2022
Lymphoma-based therapy for refractory or relapsed Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in children.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2022, Volume: 121, Issue:11

    Topics: Child; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Retrospective Studies

2022
[Safety and the short-term efficacy of bendamustine in the conditioning regimen for autologous stem cell transplantation in patients with lymphoma].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2022, Jan-14, Volume: 43, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Transplantation Conditioning; Transplantation, Autologous

2022
A gemcitabine-based regimen followed by autologous stem cell transplantation show high efficacy and well tolerance in malignant lymphoma.
    Bone marrow transplantation, 2022, Volume: 57, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Etoposide; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous

2022
Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma.
    Hematology (Amsterdam, Netherlands), 2022, Volume: 27, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Retrospective Studies; Semustine; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous

2022
High dose melphalan is an adequate preparative regimen for autologous hematopoietic stem cell transplantation in relapsed/refractory lymphoma.
    Hematology (Amsterdam, Netherlands), 2022, Volume: 27, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Transplantation Conditioning; Transplantation, Autologous

2022
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network.
    Bone marrow transplantation, 2022, Volume: 57, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Neoplasm Recurrence, Local; Prospective Studies; Thiotepa; Transplantation, Autologous; Treatment Outcome

2022
The potential efficacy and mechanism of bendamustine in entra-nodal NK/T cell lymphoma.
    Hematological oncology, 2022, Volume: 40, Issue:4

    Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Bendamustine Hydrochloride; Caspases; Cell Line, Tumor; Cell Proliferation; Cyclin B1; Etoposide; Humans; Lymphoma; Lymphoma, T-Cell; Mice; Poly(ADP-ribose) Polymerase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Ribose; Tumor Suppressor Protein p53

2022
Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.
    Cancer reports (Hoboken, N.J.), 2022, Volume: 5, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma; Lymphoma, T-Cell; Retrospective Studies; Treatment Outcome

2022
Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma.
    Blood advances, 2022, 11-22, Volume: 6, Issue:22

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; COVID-19; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; In Situ Hybridization, Fluorescence; Lymphoma; Lymphoma, B-Cell; Prednisone; Retrospective Studies; Rituximab; Transplantation, Autologous; Vincristine

2022
Clinical characteristics and treatment of NK/T-cell lymphoma-associated HLH.
    Annals of hematology, 2022, Volume: 101, Issue:10

    Topics: Dexamethasone; Etoposide; Humans; Lactate Dehydrogenases; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Lymphoma, T-Cell; Retrospective Studies

2022
[Analysis of Related Factors of Autologous Peripheral Hematopoietic Stem Cell Mobilization in Patients with Lymphoma and Myeloma].
    Zhongguo shi yan xue ye xue za zhi, 2022, Volume: 30, Issue:6

    Topics: Etoposide; Febrile Neutropenia; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma; Male; Multiple Myeloma; Retrospective Studies

2022
Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma.
    Leukemia & lymphoma, 2023, Volume: 64, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous

2023
Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell Transplantation.
    Transplantation and cellular therapy, 2023, Volume: 29, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Retrospective Studies; Thiotepa; Transplantation, Autologous

2023
ATM activity in T cells is critical for immune surveillance of lymphoma in vivo.
    Leukemia, 2020, Volume: 34, Issue:3

    Topics: Alleles; Animals; Ataxia Telangiectasia Mutated Proteins; Cell Proliferation; Etoposide; Hematopoietic Stem Cell Transplantation; Lymphoma; Mice; Mice, Knockout; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome

2020
Nitrosourea, etoposide and cyclophosphamide followed by autologous stem cell transplantation for pediatric lymphoma patients.
    International journal of hematology, 2020, Volume: 111, Issue:6

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lymphoma; Male; Retrospective Studies; Survival Rate; Transplantation, Autologous; Treatment Outcome

2020
BEAM conditioning regimen ensures better progression-free survival compared with TEAM but not with FEAM in lymphoma patients undergoing autologous stem cell transplant.
    Leukemia & lymphoma, 2020, Volume: 61, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Progression-Free Survival; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous

2020
The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and TOP2.
    Molecular cancer therapeutics, 2020, Volume: 19, Issue:8

    Topics: Animals; Camptothecin; Carcinoma, Small Cell; Cell Line, Tumor; Chickens; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Etoposide; Female; Histones; Humans; Indans; Isoquinolines; Lung Neoplasms; Lymphoma; Mice; Mice, Nude; Molecular Targeted Therapy; Neoplasm Proteins; Poultry Diseases; Random Allocation; Recombinant Proteins; Substrate Specificity; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Xenograft Model Antitumor Assays

2020
Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome.
    Journal of cancer research and clinical oncology, 2020, Volume: 146, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Middle Aged; Nitriles; Pyrazoles; Pyrimidines; Retrospective Studies

2020
Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world data.
    International journal of hematology, 2020, Volume: 112, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Communicable Diseases; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Febrile Neutropenia; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Male; Middle Aged; Multicenter Studies as Topic; Prednisone; Retrospective Studies; Rituximab; Severity of Illness Index; Treatment Outcome; Vincristine; Young Adult

2020
Substituting carmustine for lomustine is safe and effective in the treatment of relapsed or refractory Lymphoma-a retrospective study from the BSBMT (BEAM versus LEAM).
    Bone marrow transplantation, 2021, Volume: 56, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Humans; Lomustine; Lymphoma; Melphalan; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous

2021
[A Case of Adult T-Cell Leukemia/Lymphoma with Severe Hand-Foot Syndrome during Administration of Modified LSG15 Regimen].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hand-Foot Syndrome; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma; Middle Aged; Nitrosourea Compounds; Prednisolone; Vincristine; Vindesine

2020
Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism.
    Nucleic acids research, 2020, 12-16, Volume: 48, Issue:22

    Topics: Apoptosis; Cell Proliferation; Cisplatin; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Humans; Jurkat Cells; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Mitochondria; Oxidation-Reduction; Oxidative Stress; Phosphorylation; Primary Cell Culture; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Serine

2020
[IEAC versus CEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for lymphoma: analysis of efficacy and safety in 106 cases].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2020, Dec-30, Volume: 40, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Neoplasm Recurrence, Local; Retrospective Studies; Transplantation, Autologous

2020
Clinical feasibility of oral low-dose etoposide and sobuzoxane for conventional chemotherapy-intolerant lymphoma patients.
    Expert review of anticancer therapy, 2021, Volume: 21, Issue:7

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Feasibility Studies; Humans; Lymphoma; Piperazines; Prospective Studies

2021
Comparison of Mitoxantrone-Melphalan and BEAM Conditioning Regimens in Patients with Lymphoma.
    Hematology/oncology and stem cell therapy, 2022, Dec-23, Volume: 15, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Mitoxantrone; Transplantation Conditioning; Transplantation, Autologous

2022
Transcription activator, hyaluronic acid and tocopheryl succinate multi-functionalized novel lipid carriers encapsulating etoposide for lymphoma therapy.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 91

    Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Endocytosis; Etoposide; Humans; Hyaluronic Acid; Inhibitory Concentration 50; Lipids; Lymphoma; Male; Mice, Inbred C57BL; Nanoparticles; Particle Size; Proton Magnetic Resonance Spectroscopy; Static Electricity; Succinates; tat Gene Products, Human Immunodeficiency Virus; Tissue Distribution; Tocopherols

2017
Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma.
    PloS one, 2017, Volume: 12, Issue:5

    Topics: Administration, Intravenous; Animals; Antineoplastic Agents; Dog Diseases; Dogs; Etoposide; Lymphoma; Neoplasm Grading; Neoplasm Staging; Organophosphorus Compounds; Treatment Outcome; Tumor Burden

2017
Proteomic characterization of EL4 lymphoma-derived tumors upon chemotherapy treatment reveals potential roles for lysosomes and caspase-6 during tumor cell death in vivo.
    Proteomics, 2017, Volume: 17, Issue:12

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 6; Cyclophosphamide; Etoposide; Female; Lymphoma; Lysosomes; Mice; Mice, Inbred C57BL; Proteome; Proteomics; Tumor Cells, Cultured

2017
Incidence and prognostic significance of nephrotoxicity in patients receiving eshap as salvage therapy for lymphoma.
    Leukemia research, 2017, Volume: 58

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Humans; Incidence; Kaplan-Meier Estimate; Kidney Diseases; Lymphoma; Male; Methylprednisolone; Middle Aged; Outpatients; Prognosis; Proportional Hazards Models; Retrospective Studies; Salvage Therapy; Young Adult

2017
[Dose-adjusted EPOCH/EDOCH plus rituximab in untreated double-protein expression lymphoma].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2017, Jun-14, Volume: 38, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma; Prednisone; Rituximab; Vincristine

2017
Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection days.
    Journal of clinical apheresis, 2018, Volume: 33, Issue:3

    Topics: Adolescent; Adult; Aged; Antigens, CD34; Blood Component Removal; Etoposide; Febrile Neutropenia; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Patient Readmission; Peripheral Blood Stem Cells; Time Factors; Transplantation, Autologous; Young Adult

2018
Pregnancy-associated hemophagocytic lymphohistiocytosis secondary to NK/T cells lymphoma: A case report and literature review.
    Medicine, 2017, Volume: 96, Issue:47

    Topics: Adult; Antineoplastic Agents; Bone Marrow Examination; Dexamethasone; Diagnosis, Differential; Etoposide; Fatal Outcome; Female; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Natural Killer T-Cells; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Rituximab; Spleen

2017
Comparison of Nutrition-Related Adverse Events and Clinical Outcomes Between ICE (Ifosfamide, Carboplatin, and Etoposide) and MCEC (Ranimustine, Carboplatin, Etoposide, and Cyclophosphamide) Therapies as Pretreatment for Autologous Peripheral Blood Stem C
    Medical science monitor basic research, 2018, Feb-05, Volume: 24

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Energy Intake; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Nitrosourea Compounds; Nutritional Physiological Phenomena; Peripheral Blood Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Young Adult

2018
Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients.
    Haematologica, 2018, Volume: 103, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Consolidation Chemotherapy; Cytarabine; Etoposide; Humans; Lymphoma; Remission Induction; Survival Analysis; Treatment Outcome

2018
Long-term complete remission following tandem autologous stem cell transplantation and consolidative radiotherapy for refractory mediastinal gray-zone lymphoma.
    International journal of hematology, 2018, Volume: 108, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Autografts; Chemoradiotherapy; Consolidation Chemotherapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma; Male; Mediastinal Neoplasms; Prednisone; Remission Induction; Rituximab; Stem Cell Transplantation; Vincristine

2018
High-dose Bendamustine-EAM followed by autologous stem cell rescue results in long-term remission rates in lymphoma patients, without renal toxicity.
    European journal of haematology, 2018, Volume: 101, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult

2018
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018, Volume: 24, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Italy; Lymphoma; Male; Melphalan; Middle Aged; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous

2018
A retrospective multicentre study of COCKLE, an oral chemotherapy regimen, as palliative treatment for high grade lymphoma.
    British journal of haematology, 2019, Volume: 185, Issue:4

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lomustine; Lymphoma; Male; Palliative Care; Prednisolone; Recurrence; Retrospective Studies; Rituximab

2019
Modified BuCy is an alternative conditioning regimen for lymphoma patients undergoing autologous stem cell transplantation.
    Annals of hematology, 2019, Volume: 98, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Busulfan; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Semustine; Survival Rate; Transplantation Conditioning

2019
Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma.
    Annals of hematology, 2019, Volume: 98, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Busulfan; Central Nervous System Neoplasms; Consolidation Chemotherapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Lymphoma; Male; Middle Aged; Prospective Studies; Registries; Stem Cell Transplantation; Survival Rate; Thiotepa

2019
CBeV (cyclophosphamide, bendamustine and etoposide) pre-autotransplant conditioning in persons with lymphoma.
    Bone marrow transplantation, 2020, Volume: 55, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Autografts; Bendamustine Hydrochloride; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Transplantation Conditioning; Transplantation, Autologous

2020
Evaluation of thiamine for the prevention of ifosfamide-induced encephalopathy.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carboplatin; Cohort Studies; Etoposide; Female; Humans; Ifosfamide; Incidence; Lymphoma; Male; Middle Aged; Neurotoxicity Syndromes; Retrospective Studies; Thiamine

2020
Fatal cisplatin overdose in the treatment of mediastinal lymphoma with the ESHAP regimen - analysis of the causes of the adverse drug event.
    Onkologie, 2013, Volume: 36, Issue:1-2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Overdose; Etoposide; Fatal Outcome; Female; Humans; Lymphoma; Mediastinal Neoplasms; Medication Errors; Methylprednisolone

2013
Analysis of image heterogeneity using 2D Minkowski functionals detects tumor responses to treatment.
    Magnetic resonance in medicine, 2014, Volume: 71, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Etoposide; Female; Image Interpretation, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Neoplasm Staging; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Stilbenes; Treatment Outcome

2014
Conditioning regimen with BCNU, etoposide, cytarabine and melphalan plus amifostine for outpatient autologous stem cell transplant: feasibility and outcome in 97 patients with lymphoma.
    Leukemia & lymphoma, 2014, Volume: 55, Issue:7

    Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Outpatients; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome

2014
Treg depletion followed by intracerebral CpG-ODN injection induce brain tumor rejection.
    Journal of neuroimmunology, 2014, Feb-15, Volume: 267, Issue:1-2

    Topics: Adjuvants, Immunologic; Animals; Antibodies; Antigens, Ly; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cytokines; Disease Models, Animal; Etoposide; Flow Cytometry; Gene Expression Regulation, Neoplastic; Interleukin-2 Receptor alpha Subunit; Killer Cells, Natural; Lymphoma; Memory Disorders; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; NK Cell Lectin-Like Receptor Subfamily B; Oligodeoxyribonucleotides; T-Lymphocytes, Regulatory; Time Factors; Toll-Like Receptor 9

2014
Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients.
    The American journal of medicine, 2014, Volume: 127, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Aspartate Aminotransferases; Bilirubin; C-Reactive Protein; Etoposide; Female; Ferritins; Fever; France; Glucocorticoids; Hemoglobins; Humans; Immunocompromised Host; L-Lactate Dehydrogenase; Leukocyte Count; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Middle Aged; Multiple Organ Failure; Platelet Count; Retrospective Studies; Sodium; Triglycerides

2014
Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal dose.
    Bone marrow transplantation, 2014, Volume: 49, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Male; Melphalan; Middle Aged; Transplantation Conditioning; Young Adult

2014
BEAM-conditioned autologous SCT improves the quality of response in Waldenström's macroglobulinaemia and lymphoplasmacytic lymphoma: a single centre's 10-year experience.
    Bone marrow transplantation, 2014, Volume: 49, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Humans; Lymphoma; Male; Melphalan; Middle Aged; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Waldenstrom Macroglobulinemia

2014
Factors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantation.
    Journal of clinical apheresis, 2014, Volume: 29, Issue:6

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma; Male; Mesna; Middle Aged; Retrospective Studies; Rituximab; Salvage Therapy; Transplantation, Autologous; Young Adult

2014
Cytotoxic effect of the biotechnologically-derived justicidin B on human lymphoma cells.
    Biotechnology letters, 2014, Volume: 36, Issue:11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Dioxolanes; Etoposide; Female; Humans; Lignans; Lymphoma; Male; Mice; NF-kappa B

2014
[Successful treatment with oral low-dose sobuzoxane and etoposide combined with rituximab in an elderly patient with HHV-8-negative primary effusion lymphoma-like lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Herpesvirus 8, Human; Humans; Lymphoma; Lymphoma, Primary Effusion; Male; Piperazines; Rituximab

2014
High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma.
    Leukemia & lymphoma, 2015, Volume: 56, Issue:8

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease Progression; Etoposide; Female; France; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Prognosis; Recurrence; Retrospective Studies; Survival Analysis; Transplantation, Autologous; Treatment Outcome

2015
Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China.
    Orphanet journal of rare diseases, 2015, Feb-15, Volume: 10

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; China; Cyclosporine; Etoposide; Female; Glucocorticoids; Health Knowledge, Attitudes, Practice; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Middle Aged; Retrospective Studies; Young Adult

2015
Autologous Stem-Cell Transplantation Without Hematopoietic Support for the Treatment of Hematologic Malignancies in Jehovah's Witnesses.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, May-20, Volume: 33, Issue:15

    Topics: Adult; Aged; Aminocaproic Acid; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Carmustine; Combined Modality Therapy; Cyclophosphamide; Erythropoietin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hemoglobins; Humans; Iron; Jehovah's Witnesses; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Recurrence; Stem Cell Transplantation; Transplantation, Autologous; Vitamin K 1; Young Adult

2015
Long-term ovarian function in women treated with CHOP or CHOP plus etoposide for aggressive lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:8

    Topics: Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Menopause, Premature; Middle Aged; Ovarian Function Tests; Prednisone; Primary Ovarian Insufficiency; Surveys and Questionnaires; Survivors; Vincristine

2015
[Efficacy of R±BEACOP regimen in patients with 
poor-prognosis lymphoma].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2015, Volume: 40, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Rituximab; Vincristine

2015
Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Lymphomas.
    Chinese medical journal, 2015, Sep-20, Volume: 128, Issue:18

    Topics: Adolescent; Adult; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous; Young Adult

2015
Nelarabine, cyclosphosphamide and etoposide for adults with relapsed T-cell acute lymphoblastic leukaemia and lymphoma.
    British journal of haematology, 2016, Volume: 174, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Salvage Therapy

2016
The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
    Journal of cancer research and clinical oncology, 2016, Volume: 142, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kaplan-Meier Estimate; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2016
Treating Adults with Hodgkin Lymphoma in the Developing World: a Hospital-Based Cohort Study from Armenia.
    Asian Pacific journal of cancer prevention : APJCP, 2016, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Armenia; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Developed Countries; Doxorubicin; Etoposide; Female; Hodgkin Disease; Hospitals; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Retrospective Studies; Vinblastine; Vincristine; Young Adult

2016
A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM.
    Bone marrow transplantation, 2016, Volume: 51, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Male; Melphalan; Middle Aged; Retrospective Studies; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous

2016
Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide Produces Comparable Outcomes to Four-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:9

    Topics: Adult; Aged; Busulfan; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Liver Function Tests; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Respiratory Function Tests; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; Young Adult

2016
Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan.
    Annals of hematology, 2016, Volume: 95, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Febrile Neutropenia; Female; Humans; Lymphoma; Male; Melphalan; Middle Aged; Nausea; Nitrosourea Compounds; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult

2016
Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.
    British journal of haematology, 2017, Volume: 179, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma; Mediastinal Neoplasms; Prednisone; Rituximab; Survival Rate; Treatment Outcome; Vincristine

2017
Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.
    British journal of haematology, 2017, Volume: 179, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma; Methotrexate; Prednisone; Rituximab; Treatment Outcome; Vincristine

2017
Factors and Costs Associated With Delay in Treatment Initiation and Prolonged Length of Stay With Inpatient EPOCH Chemotherapy in Patients With Hematologic Malignancies.
    Cancer investigation, 2017, Mar-16, Volume: 35, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Health Care Costs; Humans; Inpatients; Length of Stay; Leukemia; Lymphoma; Male; Middle Aged; Prednisone; Treatment Outcome; Vincristine

2017
Topoisomerase II inhibition involves characteristic chromosomal expression patterns.
    BMC genomics, 2008, Jul-08, Volume: 9

    Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chlorodiphenyl (54% Chlorine); Chromosome Mapping; Chromosomes, Human; Chromosomes, Mammalian; Doxorubicin; Enzyme Inhibitors; Etoposide; Female; Fluoroquinolones; Gene Expression Regulation; Hepatocytes; Humans; Lymphocytes; Lymphoma; Mice; Mice, Transgenic; Naphthyridines; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins c-myc; Topoisomerase II Inhibitors; Transcription Factors; Transcription, Genetic

2008
A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment.
    Neoplasia (New York, N.Y.), 2009, Volume: 11, Issue:6

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carbon Isotopes; Carbon Radioisotopes; Cell Line, Tumor; Etoposide; Female; Flow Cytometry; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Lactates; Lymphoma; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Poly(ADP-ribose) Polymerases; Positron-Emission Tomography; Pyruvates; Treatment Outcome

2009
Palonosetron in prevention of nausea and vomiting after highly emetogenic chemotherapy before haematopoietic stem cell transplantation-single center experience.
    Transplantation proceedings, 2009, Volume: 41, Issue:8

    Topics: Antineoplastic Agents; Carmustine; Emetics; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Isoquinolines; Lymphoma; Nausea; Ondansetron; Palonosetron; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vomiting

2009
Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors.
    Proceedings of the National Academy of Sciences of the United States of America, 2009, Nov-24, Volume: 106, Issue:47

    Topics: Animals; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Carbon Isotopes; Etoposide; Female; Fumarate Hydratase; Fumarates; Lymphoma; Malates; Mice; Mice, Inbred C57BL; Necrosis; Neoplasm Transplantation; Neoplasms; Nuclear Magnetic Resonance, Biomolecular; Tissue Extracts; Treatment Outcome

2009
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi.
    Leukemia & lymphoma, 2010, Volume: 51, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine

2010
ESHAP versus rituximab-ESHAP in frail patients with refractory diffuse large B-cell lymphoma.
    Clinical lymphoma, myeloma & leukemia, 2010, Volume: 10, Issue:2

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cisplatin; Colony-Stimulating Factors; Cytarabine; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Remission Induction; Rituximab

2010
Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation.
    Bone marrow transplantation, 2011, Volume: 46, Issue:12

    Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Agents, Phytogenic; Blood Component Removal; Databases, Factual; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Lymphoma; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Platelet Count; Recovery of Function; Retrospective Studies; Survival Rate; Transplantation, Autologous

2011
Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia.
    Bone marrow transplantation, 2012, Volume: 47, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Lymphoma; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Risk Factors; Young Adult

2012
FAME, a novel conditioning regimen for allogeneic stem cell transplantation for lymphoma, does not earn fame.
    Hematological oncology, 2012, Volume: 30, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Middle Aged; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2012
Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation.
    Transfusion, 2011, Volume: 51, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Rituximab; Transplantation, Autologous; Young Adult

2011
Platine and cytarabine-based salvage treatment for primary central nervous system lymphoma.
    Journal of neuro-oncology, 2011, Volume: 105, Issue:2

    Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rituximab; Salvage Therapy; Thiotepa; Young Adult

2011
Long-term survival in patients with newly diagnosed primary central nervous system lymphoma treated with dexamethasone, etoposide, ifosfamide and carboplatin chemotherapy and whole-brain radiation therapy.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:11

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Chemoradiotherapy; Cognition Disorders; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lymphoma; Male; Middle Aged; Outcome Assessment, Health Care; Radiotherapy; Retrospective Studies; Survivors; Young Adult

2011
Acquired STAT4 deficiency as a consequence of cancer chemotherapy.
    Blood, 2011, Dec-01, Volume: 118, Issue:23

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Boronic Acids; Bortezomib; Carmustine; Cells, Cultured; Drug Interactions; Etoposide; Flow Cytometry; Gene Expression; Humans; Interleukin-12; Interleukin-2; Leukocytes, Mononuclear; Lymphoma; Melanoma; Mice; Mice, Inbred C57BL; Protein Biosynthesis; Pyrazines; RNA Stability; Skin Neoplasms; STAT4 Transcription Factor; Ubiquitin

2011
Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lymphoma; Male; Mediastinum; Middle Aged; Pneumonia; Radiation, Ionizing; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Young Adult

2012
BCNU-associated pneumonitis: portrait of a toxicity.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma; Male; Pneumonia; Stem Cell Transplantation

2012
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Mar-10, Volume: 30, Issue:8

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Flow Cytometry; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-15; Interleukin-7; Lymphocyte Depletion; Lymphoma; Male; Middle Aged; Prednisone; Rituximab; Salvage Therapy; Treatment Outcome; Vidarabine; Vincristine

2012
Induction of apoptosis in Eμ-myc lymphoma cells in vitro and in vivo through calpain inhibition.
    Experimental hematology, 2012, Volume: 40, Issue:7

    Topics: Acrylates; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; B-Lymphocytes; Calcium-Binding Proteins; Calpain; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cysteine Proteinase Inhibitors; Etoposide; Humans; Lymphoma; Mice; Mice, Transgenic

2012
Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and etoposide results in predictable drug levels and durable long-term survival in lymphoma patients undergoing autologous stem cell transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2012, Volume: 18, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cohort Studies; Cyclophosphamide; Drug Administration Routes; Etoposide; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous

2012
Orbital plasmablastic lymphoma with remission following chemotherapy.
    Journal of radiology case reports, 2011, Volume: 5, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Multimodal Imaging; Orbital Neoplasms; Polyethylene Glycols; Positron-Emission Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recombinant Proteins; Remission Induction; Tomography, X-Ray Computed; Vincristine

2011
Metronomic therapy for refractory/relapsed lymphoma: the PEP-C low-dose oral combination chemotherapy regimen.
    Hematology (Amsterdam, Netherlands), 2012, Volume: 17 Suppl 1

    Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Endothelial Cells; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Lymphoma; Prednisone; Procarbazine; Receptors, Vascular Endothelial Growth Factor; Secondary Prevention; Vascular Endothelial Growth Factor A

2012
Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells.
    Blood, 2012, Jun-14, Volume: 119, Issue:24

    Topics: Aniline Compounds; Animals; Apoptosis Regulatory Proteins; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Bcl-2-Like Protein 11; bcl-X Protein; Biphenyl Compounds; Cell Death; Cytoprotection; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Lymphoma; Membrane Proteins; Mice; Molecular Targeted Therapy; Mutant Proteins; Myeloid Cell Leukemia Sequence 1 Protein; Nitrophenols; Piperazines; Protein Binding; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Sulfonamides

2012
Neither loss of Bik alone, nor combined loss of Bik and Noxa, accelerate murine lymphoma development or render lymphoma cells resistant to DNA damaging drugs.
    Cell death & disease, 2012, May-10, Volume: 3

    Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; DNA Damage; Drug Resistance, Neoplasm; Etoposide; Female; Lymphoma; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondrial Proteins; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Tumor Suppressor Protein p53

2012
The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation.
    Nucleic acid therapeutics, 2012, Volume: 22, Issue:4

    Topics: 3' Untranslated Regions; Antineoplastic Agents, Phytogenic; Base Sequence; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Down-Regulation; Etoposide; Gene Expression; Green Fluorescent Proteins; Humans; Imidazoles; Lymphoma; MicroRNAs; Piperazines; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; RNA Interference; Transfection; Tumor Suppressor Protein p53

2012
Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.
    Haematologica, 2002, Volume: 87, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Recurrence; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome

2002
Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma.
    Bone marrow transplantation, 2002, Volume: 30, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Data Collection; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous

2002
VIII International Conference on malignant lymphoma. June 12-15, 2002 Lugano, Switzerland.
    Clinical lymphoma, 2002, Volume: 3, Issue:2

    Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Lymphoma; Lymphoma, Mantle-Cell; Middle Aged; Paclitaxel; Prednisone; Rituximab; Time Factors; Topotecan; Treatment Outcome; Vincristine

2002
Excellent long-term survival in patients with early-stage primary bone lymphoma treated with doxorubicin-based chemotherapy and local radiotherapy.
    American journal of clinical oncology, 2002, Volume: 25, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Prednisone; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome; Vincristine

2002
Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma.
    British journal of cancer, 2003, Jan-13, Volume: 88, Issue:1

    Topics: Animals; Antineoplastic Agents; Dacarbazine; Disease Models, Animal; Drug Therapy, Combination; Etoposide; Humans; Lymphoma; Male; Melanoma, Experimental; Mice; Mice, Inbred CBA; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Peptides, Cyclic; Somatostatin; Xenograft Model Antitumor Assays

2003
When lymphoma and heart failure cross paths.
    Journal of hematotherapy & stem cell research, 2003, Volume: 12, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Echocardiography; Etoposide; Female; Heart Neoplasms; Humans; Lymphoma; Prednisolone; Prednisone; Treatment Outcome; Vincristine

2003
Current status and future of relapsed primary central nervous system lymphoma (PCNSL).
    Leukemia & lymphoma, 2003, Volume: 44, Issue:4

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Organophosphorus Compounds; Radioimmunotherapy; Recurrence; Rituximab; Time Factors

2003
Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity.
    Mutagenesis, 2003, Volume: 18, Issue:4

    Topics: Animals; Anti-Infective Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Ciprofloxacin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Genistein; Lymphoma; Mice; Mutagens; Topoisomerase I Inhibitors

2003
Evaluation for the development of 11q23 rearrangements in lymphoma patients treated with a high dose VP-16 and cyclophosphamide salvage regimen.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Bone Marrow; Chromosome Mapping; Chromosomes, Human, Pair 11; Cyclophosphamide; DNA, Neoplasm; Etoposide; Exons; Female; Gene Rearrangement; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Salvage Therapy

2003
Caspase 3-mediated inactivation of rac GTPases promotes drug-induced apoptosis in human lymphoma cells.
    Molecular and cellular biology, 2003, Volume: 23, Issue:16

    Topics: Apoptosis; Caspase 3; Caspase 8; Caspase 9; Caspases; Cytoskeleton; Down-Regulation; Etoposide; Genetic Vectors; Humans; Lymphoma; Models, Molecular; Mutagenesis, Site-Directed; Mutation; p21-Activated Kinases; Plasmids; Protein Binding; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; rac GTP-Binding Proteins; Recombinant Proteins; Signal Transduction; Staurosporine; Time Factors; Transfection; Tumor Cells, Cultured

2003
Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor.
    Annals of hematology, 2003, Volume: 82, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Neutropenia; Recurrence; Remission Induction; Thrombocytopenia; Tomography, X-Ray Computed; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome

2003
Effects of etoposide and fludarabine in subtoxic doses on karyotype of human malignant lymphoid Namalwa cells.
    Bulletin of experimental biology and medicine, 2003, Volume: 136, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chromatids; Chromosome Aberrations; Chromosomes; Culture Media; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Humans; Karyotyping; Lymphoma; Mutagens; Vidarabine

2003
Association of intestinal malignant lymphoma and ulcerative colitis.
    Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colitis, Ulcerative; Colonoscopy; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphoma; Methotrexate; Peripheral Blood Stem Cell Transplantation; Sigmoid Neoplasms; Vincristine

2003
Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphoma.
    Bone marrow transplantation, 2004, Volume: 33, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Humans; Lymphoma; Platelet Transfusion; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome

2004
[A case of isolated hepatic malignant lymphoma representing characteristic findings on radiological imaging].
    Fukuoka igaku zasshi = Hukuoka acta medica, 2003, Volume: 94, Issue:11

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Irinotecan; L-Lactate Dehydrogenase; Liver Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Prednisolone; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2003
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Feb-15, Volume: 10, Issue:4

    Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis Regulatory Proteins; bcl-X Protein; Caspase 3; Caspase 8; Caspases; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Activation; Etoposide; Flow Cytometry; Humans; Immunoblotting; Jurkat Cells; Ligands; Lymphoma; Membrane Glycoproteins; Membrane Potentials; Organoplatinum Compounds; Oxaliplatin; Proto-Oncogene Proteins c-bcl-2; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha

2004
Rac1 inhibits apoptosis in human lymphoma cells by stimulating Bad phosphorylation on Ser-75.
    Molecular and cellular biology, 2004, Volume: 24, Issue:14

    Topics: Animals; Apoptosis; bcl-Associated Death Protein; Carrier Proteins; Caspases; Cell Line, Tumor; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Humans; Lymphoma; Mice; Nucleic Acid Synthesis Inhibitors; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; rac1 GTP-Binding Protein; Recombinant Fusion Proteins; Serine; Signal Transduction

2004
High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.
    Bone marrow transplantation, 2004, Volume: 34, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Length of Stay; Lymphoma; Male; Melphalan; Middle Aged; Podophyllotoxin; Prognosis; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome

2004
The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive Non-Hodgkin's Lymphoma (NHL).
    Journal of experimental & clinical cancer research : CR, 2004, Volume: 23, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Follow-Up Studies; Humans; Interleukin-10; Interleukin-2; Interleukin-6; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Regression Analysis; Time Factors; Treatment Outcome; Vincristine

2004
Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma.
    Haematologica, 2005, Volume: 90, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow; Bone Marrow Transplantation; Carmustine; Chemotherapy, Adjuvant; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Male; Melphalan; Middle Aged; Multivariate Analysis; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous

2005
Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
    The Journal of biological chemistry, 2005, Apr-01, Volume: 280, Issue:13

    Topics: Alleles; Animals; Apoptosis; B-Lymphocytes; bcl-X Protein; Blotting, Western; Bone Marrow Cells; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Enhancer Elements, Genetic; Etoposide; Flow Cytometry; Gene Rearrangement; Genes, Regulator; Genetic Vectors; Immunoglobulin Heavy Chains; Lymphoma; Mice; Mice, Transgenic; Models, Genetic; Nuclear Proteins; Promoter Regions, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-mdm2; Proto-Oncogene Proteins c-myc; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Spleen; Time Factors; Transfection

2005
Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
    Annals of hematology, 2005, Volume: 84, Issue:7

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Pneumonia; Prednisone; Procarbazine; Retrospective Studies; Sepsis; Vincristine

2005
Reduced intensity conditioning compared to standard conditioning preserves the in vitro growth capacity of bone marrow stroma, which remains of host origin.
    Stem cells and development, 2005, Volume: 14, Issue:2

    Topics: Adult; Aged; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Bone Marrow Transplantation; Busulfan; Cell Culture Techniques; Cell Proliferation; Cell Transplantation; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cells; Humans; Immunohistochemistry; Immunosuppressive Agents; In Situ Hybridization, Fluorescence; Lewis X Antigen; Lipopolysaccharide Receptors; Lymphoma; Male; Microscopy, Fluorescence; Middle Aged; Myelodysplastic Syndromes; Nucleic Acid Synthesis Inhibitors; Stromal Cells; Transplantation Conditioning; Vidarabine

2005
Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice.
    Journal of controlled release : official journal of the Controlled Release Society, 2005, Jul-20, Volume: 105, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Chelating Agents; Cysteine; Drug Carriers; Etoposide; Humans; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Liposomes; Lymphoma; Mice; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Palmitic Acid; Particle Size; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Tin Compounds; Tissue Distribution

2005
IIVP salvage regimen induces high response rates in patients with relapsed lymphoma before autologous stem cell transplantation.
    American journal of clinical oncology, 2005, Volume: 28, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Hodgkin Disease; Humans; Idarubicin; Ifosfamide; Infections; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Salvage Therapy; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome

2005
Regulation of the expression of caspase-9 by the transcription factor activator protein-4 in glucocorticoid-induced apoptosis.
    The Journal of biological chemistry, 2005, Jul-29, Volume: 280, Issue:30

    Topics: Animals; Apoptosis; Apoptotic Protease-Activating Factor 1; bcl-2-Associated X Protein; bcl-X Protein; Binding Sites; Blotting, Western; Caspase 9; Caspases; Cell Line; Cell Line, Tumor; Cell Survival; Cloning, Molecular; Dexamethasone; DNA-Binding Proteins; Etoposide; Gene Expression Regulation, Enzymologic; Glucocorticoids; Kinetics; Lymphoma; Mice; Mutation; Oligonucleotides, Antisense; Promoter Regions, Genetic; Proteins; Proto-Oncogene Proteins c-bcl-2; Thymus Neoplasms; Time Factors; Transcription Factors; Transfection

2005
1H MRS-visible lipids accumulate during apoptosis of lymphoma cells in vitro and in vivo.
    Magnetic resonance in medicine, 2005, Volume: 54, Issue:1

    Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Count; Cell Line, Tumor; Etoposide; Female; Lipid Metabolism; Lymphoma; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Protons; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic

2005
Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis.
    Cancer research, 2005, Jul-15, Volume: 65, Issue:14

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Base Sequence; Breast Neoplasms; Caspase 3; Caspase Inhibitors; Caspases; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Guanine Nucleotide Dissociation Inhibitors; Humans; Lymphoma; Molecular Sequence Data; Mutation; rac1 GTP-Binding Protein; rho Guanine Nucleotide Dissociation Inhibitor alpha; rho-Specific Guanine Nucleotide Dissociation Inhibitors; RNA Interference; RNA, Small Interfering; Transfection

2005
[Tandem autotransplants of peripheral blood stem cells following sequential high-dose CHOEP chemotherapy for aggressive lymphoma].
    Zhongguo shi yan xue ye xue za zhi, 2005, Volume: 13, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Retrospective Studies; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine

2005
Epstein-Barr virus infected natural killer cell lymphoma in a patient with hypersensitivity to mosquito bite.
    The Journal of infection, 2006, Volume: 52, Issue:6

    Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Culicidae; Epstein-Barr Virus Infections; Etoposide; Glyoxal; Humans; Hypersensitivity; Ifosfamide; Insect Bites and Stings; Killer Cells, Natural; Lymph Nodes; Lymphocytes; Lymphoma; Male; Prednimustine; Skin

2006
Evaluation of the role of caspase-6 in anticancer drug-induced apoptosis.
    Cell death and differentiation, 2006, Volume: 13, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Caspase 6; Caspases; Cell Line, Tumor; Chickens; Etoposide; Gene Expression Regulation, Neoplastic; Lymphoma

2006
Posterior leukoencephalopathy after combination chemotherapy in a patient with lymphoma.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Etoposide; Fatal Outcome; Female; Hemoglobins; Humans; Idarubicin; Ifosfamide; Leukoencephalopathy, Progressive Multifocal; Lymphoma; Magnetic Resonance Imaging

2005
[Two cases of malignant lymphoma with high fever and C-reactive protein (CRP) elevation after treatment with granulocyte colony-stimulating factor (G-CSF)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:1

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma; Lymphoma, Mantle-Cell; Male; Middle Aged; Prednisone; Recombinant Proteins; Rituximab; Vincristine

2006
Correlation between decreased sensitivity of the Daudi lymphoma cells to VP-16-induced apoptosis and deficiency in DNAS1L3 expression.
    Biochemical and biophysical research communications, 2006, Mar-10, Volume: 341, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; bcl-Associated Death Protein; Calcium; Caspase 3; Caspases; Cell Line, Tumor; Deoxyribonucleases; DNA; DNA Damage; DNA Fragmentation; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Endodeoxyribonucleases; Enzyme Activation; Etoposide; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; In Situ Nick-End Labeling; Intracellular Signaling Peptides and Proteins; Lymphoma; Magnesium; Membrane Potentials; Nucleosomes; Poly-ADP-Ribose Binding Proteins; Proteins; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Transfection; U937 Cells

2006
Enhanced delivery of etoposide to Dalton's lymphoma in mice through polysorbate 20 micelles.
    Acta pharmaceutica (Zagreb, Croatia), 2006, Volume: 56, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Carriers; Drug Stability; Etoposide; Injections, Subcutaneous; Lymphoma; Mice; Mice, Inbred BALB C; Micelles; Particle Size; Polysorbates; Technetium; Tissue Distribution

2006
Tumoricidal effects of etoposide incorporated into solid lipid nanoparticles after intraperitoneal administration in Dalton's lymphoma bearing mice.
    The AAPS journal, 2006, Apr-14, Volume: 8, Issue:2

    Topics: Animals; Apoptosis; Disease Models, Animal; Etoposide; Lymphoma; Mice; Mice, Inbred BALB C; Micronucleus Tests; Nanostructures; Treatment Outcome

2006
Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up.
    Annals of hematology, 2006, Volume: 85, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Retrospective Studies; Time Factors; Vincristine

2006
Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines.
    Investigational new drugs, 2007, Volume: 25, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Benzamides; Camptothecin; Carboplatin; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Cytarabine; Depsipeptides; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Imatinib Mesylate; Irinotecan; K562 Cells; Leukemia; Lymphoma; Mercaptopurine; Piperazines; Pyrimidines; Time Factors

2007
Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
    American journal of ophthalmology, 2007, Volume: 144, Issue:1

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carotid Artery, Internal; Catheterization, Peripheral; Cyclophosphamide; Cytarabine; Etoposide; Female; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Male; Mannitol; Methotrexate; Middle Aged; Pigment Epithelium of Eye; Retinal Diseases; Retrospective Studies; Tomography, Optical Coherence; Vertebral Artery

2007
Mobilization regimens prior to stem-cell collection in patients with lymphoma: how to choose?
    Leukemia & lymphoma, 2007, Volume: 48, Issue:10

    Topics: Antigens, CD34; Bone Marrow Cells; Chemokine CXCL12; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Lymphoma; Recurrence; Risk; Stem Cell Transplantation; Treatment Outcome

2007
[Comparison of salvage chemotherapy regimen ACES with ESHAP for refractory or relapsed malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation

2007
[Comparison of regimen-related toxicity between high-dose melphalan and ICE as a preparatory regimen for autologous stem cell transplantation].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Stem Cell Transplantation; Transplantation, Autologous

2007
Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy.
    Nature medicine, 2007, Volume: 13, Issue:11

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carbon Isotopes; Cell Death; Cell Line, Tumor; Etoposide; Lactate Dehydrogenases; Lactic Acid; Lymphoma; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Neoplasm Transplantation; Pyruvic Acid

2007
Long-term follow-up of busulfan, etoposide, and nimustine hydrochloride (ACNU) or melphalan as conditioning regimens for childhood acute leukemia and lymphoma.
    International journal of hematology, 2007, Volume: 86, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Infant; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Nimustine; Recurrence; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous

2007
Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
    American journal of ophthalmology, 2007, Volume: 144, Issue:6

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cyclophosphamide; Cytarabine; Etoposide; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Mannitol; Methotrexate; Pigment Epithelium of Eye; Retinal Diseases

2007
Detection of cell death in tumors by using MR imaging and a gadolinium-based targeted contrast agent.
    Radiology, 2008, Volume: 246, Issue:3

    Topics: Analysis of Variance; Animals; Apoptosis; Carbohydrate Sulfotransferases; Contrast Media; Etoposide; Female; Flow Cytometry; Fluorescein; Gadolinium DTPA; In Situ Nick-End Labeling; Liposomes; Lymphoma; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Phosphatidylserines; Prospective Studies; Protein Binding; Sulfotransferases; Tumor Cells, Cultured

2008
[High-dose ifosfamide and etoposide regimen as salvage and mobilization therapy for patients with lymphoma].
    Medicina clinica, 2008, Feb-16, Volume: 130, Issue:5

    Topics: Adult; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Salvage Therapy

2008
IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma.
    British journal of haematology, 2008, Volume: 141, Issue:2

    Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Evaluation; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Salvage Therapy; Treatment Outcome

2008
Results of treatment of 112 cases of primary CNS lymphoma.
    Japanese journal of clinical oncology, 2008, Volume: 38, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Cognition; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Leucovorin; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine

2008
Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type.
    The American journal of medicine, 1983, Volume: 74, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Radiography, Abdominal; Remission, Spontaneous; Time Factors; Vincristine

1983
Current problems in the management of non-Hodgkin's lymphomas.
    Cancer treatment reviews, 1984, Volume: 11, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma; Methotrexate; Prednisone; Vincristine

1984
High-dose chemoradiotherapy and bone marrow transplantation in patients with refractory lymphoma.
    European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:8

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Female; Humans; Lymphoma; Male; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation

1983
[A phase II clinical trial of oral VP 16-213 in advanced non-Hodgkin's lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:8

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Drug Resistance; Etoposide; Humans; Lymphoma; Podophyllotoxin; Vincristine

1984
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy.
    Annals of internal medicine, 1983, Volume: 98, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Leucovorin; Leukopenia; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine

1983
Erythema and desquamation after high-dose methotrexate.
    Annals of internal medicine, 1983, Volume: 98, Issue:5 Pt 1

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Erythema; Etoposide; Female; Humans; Leucovorin; Lymphoma; Methotrexate; Prednisone

1983
Treatment of refractory malignant lymphomas with ifosfamide/etoposide combination chemotherapy.
    Cancer treatment reviews, 1983, Volume: 10 Suppl A

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Lymphoma

1983
[Phase I study of an oral administration of VP 16-213].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1983, Volume: 10, Issue:11

    Topics: Administration, Oral; Adult; Aged; Capsules; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Podophyllotoxin

1983
[Phase II study of etoposide in malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:4

    Topics: Adult; Aged; Drug Evaluation; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Podophyllotoxin

1984
Etoposide as single agent and in combination with cis-platinum for malignant lymphomas.
    Cancer treatment reviews, 1982, Volume: 9 Suppl

    Topics: Adult; Aged; Blood; Cisplatin; Drug Therapy, Combination; Etoposide; Humans; Lymphoma; Middle Aged; Podophyllotoxin

1982
Cis-dichlorodiammineplatinum (II) (cis-platinum) and etoposide for patients with refractory lymphomas.
    Cancer treatment reviews, 1982, Volume: 9 Suppl

    Topics: Adult; Cisplatin; Drug Therapy, Combination; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Podophyllotoxin

1982
Interaction of VP16-213 with the DNA repair antagonist chloroquine.
    Cancer chemotherapy and pharmacology, 1982, Volume: 7, Issue:2-3

    Topics: Animals; Chloroquine; DNA Repair; Drug Interactions; Etoposide; Female; Lymphoma; Mice; Mice, Inbred CBA; Neoplasms, Experimental; Podophyllotoxin; Vincristine

1982
Etoposide as a single agent in relapsed advanced lymphomas. A phase II study.
    Cancer chemotherapy and pharmacology, 1982, Volume: 7, Issue:2-3

    Topics: Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin

1982
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy.
    Blood, 1982, Volume: 60, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Inflammation; Lymphoma; Methotrexate; Mucous Membrane; Neutropenia; Podophyllotoxin; Recurrence

1982
[Etoposide: VP-16].
    Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg, 1982, Volume: 119, Issue:2

    Topics: Etoposide; Humans; Lung Neoplasms; Lymphoma; Neoplasms; Podophyllotoxin

1982
Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.
    Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 11

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cladribine; Colorectal Neoplasms; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; In Vitro Techniques; Leukemia; Lung Neoplasms; Lymphoma; Ribonucleotide Reductases; Tumor Cells, Cultured; Urogenital Neoplasms

1995
Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis.
    Blood, 1993, Dec-15, Volume: 82, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Length of Stay; Leukapheresis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Vincristine

1993
Secondary myelodysplastic syndrome following bone marrow transplantation: report of two cases.
    Bone marrow transplantation, 1994, Volume: 13, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Myelodysplastic Syndromes; Prednisone; Procarbazine; Rectal Neoplasms; Risk Factors; Seminoma; Testicular Neoplasms; Transplantation, Autologous; Vincristine

1994
High-dose chemotherapy and autologous peripheral stem cell transplantation in patients with relapsing malignant lymphomas--first experience in the Slovak Republic.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Lymphoma; Mitoxantrone; Salvage Therapy; Slovakia

1995
High grade malignant lymphoma with clinical characteristics and immunophenotype of natural killer cells.
    American journal of hematology, 1995, Volume: 49, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Immunophenotyping; Killer Cells, Natural; Leukocyte Count; Lymphoma; Male; Prednisone; Spleen; Splenectomy; Thrombocytopenia; Vincristine

1995
Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogenic bone marrow transplantation.
    Bone marrow transplantation, 1995, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Graft vs Host Disease; Humans; Leukemia; Lung; Lymphoma; Male; Middle Aged; Recurrence; Skin; Survival Rate; Transplantation, Autologous; Transplantation, Homologous

1995
[Peripheral blood stem cell transplantation in adult patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:4

    Topics: Adolescent; Adult; Blood Cell Count; Cell Separation; Chemotherapy, Adjuvant; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1993
Predicting neutropenia after chemotherapy for lymphoma.
    Leukemia & lymphoma, 1993, Volume: 9, Issue:1-2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukocyte Count; Lymphoma; Male; Mechlorethamine; Middle Aged; Neutropenia; Predictive Value of Tests; Prednisolone; Procarbazine; Retrospective Studies; Risk Factors; Thrombocytopenia; Vinblastine; Vincristine

1993
Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma.
    Bone marrow transplantation, 1993, Volume: 11, Issue:4

    Topics: Adult; Aged; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Breast Neoplasms; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Immunologic Factors; Lymphoma; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Prednisone; Recombinant Proteins; Vincristine

1993
Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product.
    British journal of cancer, 1993, Volume: 68, Issue:5

    Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Lymphoma; Male; Melphalan; Middle Aged; Salvage Therapy; Time Factors

1993
Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:1

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Carcinoma; Chromosome Aberrations; Chromosome Disorders; Cisplatin; Etoposide; Female; Germinoma; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Karyotyping; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prospective Studies; Retroperitoneal Neoplasms; Testicular Neoplasms; Treatment Outcome

1995
Carmustine, Ara C, cyclophosphamide and etoposide with autologous bone marrow transplantation in relapsed or refractory lymphoma: a dose-finding study.
    Bone marrow transplantation, 1994, Volume: 14, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Transplantation, Autologous

1994
[Therapeutic effects of peripheral blood stem cell transplantation following combination chemotherapy using ranimustine, cytarabine, etoposide and cyclophosphamide for patients with hematological malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Lymphoma; Male; Middle Aged; Nitrosourea Compounds

1994
Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis.
    Bone marrow transplantation, 1994, Volume: 13, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Blood Component Transfusion; Busulfan; Combined Modality Therapy; Etoposide; Female; Flow Cytometry; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Leukemia, Myeloid; Leukocyte Count; Leukopenia; Lymphocyte Subsets; Lymphoma; Male; Middle Aged; Nitrosourea Compounds; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1994
Quality and functional capacity of the bone marrow microenvironment of autologous blood stem cell transplantation (ABSCT) recipients.
    Nouvelle revue francaise d'hematologie, 1994, Volume: 36, Issue:4

    Topics: Bone Marrow; Carmustine; Cells, Cultured; Colony-Forming Units Assay; Connective Tissue; Cyclophosphamide; Cytarabine; Etoposide; Graft Survival; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Multiple Myeloma; Transplantation, Autologous; Whole-Body Irradiation

1994
Potent clastogenicity of the human carcinogen etoposide to the mouse bone marrow and mouse lymphoma L5178Y cells: comparison to Salmonella responses.
    Environmental and molecular mutagenesis, 1994, Volume: 24, Issue:1

    Topics: Animals; Bone Marrow; Etoposide; Humans; Lymphoma; Male; Methylnitrosourea; Mice; Micronucleus Tests; Mutagenicity Tests; Salmonella; Tumor Cells, Cultured

1994
Germ cell failure and Leydig cell insufficiency in post-pubertal males after autologous bone marrow transplantation with BEAM for lymphoma.
    Bone marrow transplantation, 1994, Volume: 13, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Follicle Stimulating Hormone; Humans; Leydig Cells; Luteinizing Hormone; Lymphoma; Male; Melphalan; Spermatozoa; Transplantation, Autologous

1994
MINE-ESHAP salvage therapy for recurrent and refractory lymphomas.
    Seminars in hematology, 1994, Volume: 31, Issue:2 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma; Mesna; Methylprednisolone Hemisuccinate; Mitoxantrone; Neoplasm Recurrence, Local; Salvage Therapy; Survival Rate

1994
Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hemorrhage; Humans; Leukemia; Lung Diseases; Lymphoma; Male; Middle Aged; Recurrence; Survival Rate; Transplantation, Homologous; Whole-Body Irradiation

1994
Etoposide in combination with cyclophosphamide and total body irradiation or busulfan as conditioning for marrow transplantation in adults and children.
    International journal of radiation oncology, biology, physics, 1994, Apr-30, Volume: 29, Issue:1

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Infant; Leukemia; Lung Diseases, Interstitial; Lymphoma; Male; Middle Aged; Retrospective Studies; Skin Diseases; Whole-Body Irradiation

1994
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Autologous

1993
Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignancies.
    Seminars in oncology, 1993, Volume: 20, Issue:4 Suppl 4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Lymphoma; Middle Aged; Survival Analysis; Treatment Outcome

1993
High-dose cyclophosphamide, etoposide and BCNU (CVB) with autologous stem cell rescue in malignant lymphomas.
    European journal of haematology, 1993, Volume: 51, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Salvage Therapy; Stem Cell Transplantation; Time Factors; Transplantation, Autologous

1993
E-SHAP: inadequate treatment for poor-prognosis recurrent lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Lymphoma; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Treatment Outcome

1993
Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) +/- TBI and autologous BMT for malignant lymphomas.
    Bone marrow transplantation, 1993, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Glomerular Filtration Rate; Hemolytic-Uremic Syndrome; Humans; Kidney; Lymphoma; Male; Middle Aged; Transplantation, Autologous; Whole-Body Irradiation

1993
A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation.
    Experimental hematology, 1995, Volume: 23, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukapheresis; Leukocyte Count; Leukocytes, Mononuclear; Lymphoma; Lymphoma, Non-Hodgkin; Macrophages; Male; Melphalan

1995
[A case of early gastric cancer transformed from adenoma by chemotherapy and radiotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:7

    Topics: Adenoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Lymphoma; Male; Neoplasms, Second Primary; Prednisolone; Stomach Neoplasms; Tegafur; Uracil; Vincristine

1996
Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma.
    American journal of hematology, 1996, Volume: 52, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Prognosis; Remission Induction; Survival Rate

1996
High-dose carmustine, etoposide and melphalan ('BEM') with autologous stem cell transplantation: a dose-toxicity study.
    Bone marrow transplantation, 1996, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Liver Function Tests; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Respiratory Function Tests; Retrospective Studies; Transplantation, Autologous

1996
[Effects of carboplatin combination with etoposide against leukemia/lymphoma cell lines].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Humans; Leukemia; Lymphoma; Tumor Cells, Cultured

1996
Higher in vivo protein binding of etoposide in children compared with adult cancer patients.
    Cancer letters, 1996, Aug-23, Volume: 106, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Child; Child, Preschool; Etoposide; Female; Histiocytic Sarcoma; Humans; Infant; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Male; Middle Aged; Multiple Myeloma; Oligodendroglioma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Binding; Reference Values; Serum Albumin

1996
Peripheral blood stem cell support does not accelerate haemopoietic recovery from miniBEAM chemotherapy.
    Bone marrow transplantation, 1996, Volume: 18, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged

1996
Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors.
    Biochemical and biophysical research communications, 1996, Nov-01, Volume: 228, Issue:1

    Topics: Amino Acid Sequence; Animals; Antineoplastic Agents, Phytogenic; Base Sequence; Camptothecin; Cloning, Molecular; DNA, Neoplasm; Down-Regulation; Etoposide; Gene Expression Regulation, Neoplastic; Heterogeneous Nuclear Ribonucleoprotein A1; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Heterogeneous-Nuclear Ribonucleoproteins; Lymphoma; Mice; Molecular Sequence Data; Neoplasm Proteins; Radiation Leukemia Virus; Ribonucleoproteins; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1996
[Bilateral highly malignant centroblastic lymphoma of the breast].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1996, Volume: 165, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma; Magnetic Resonance Imaging; Mammography; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Stem Cell Transplantation; Tomography, X-Ray Computed; Vincristine

1996
Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay.
    Blood, 1997, May-15, Volume: 89, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biopsy; Breast Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Lung Neoplasms; Lymphoma; Neoplasm Proteins; Polymerase Chain Reaction; Prednisone; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Verapamil; Vincristine

1997
Low levels of serum soluble c-kit relates to delayed engraftment after bone marrow transplantation.
    Leukemia & lymphoma, 1997, Volume: 25, Issue:3-4

    Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Bone Marrow Transplantation; Cyclophosphamide; Etoposide; Graft Rejection; Graft vs Host Disease; Humans; Leukemia; Lymphoma; Proto-Oncogene Proteins c-kit; Transplantation Conditioning; Whole-Body Irradiation

1997
Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide.
    British journal of haematology, 1997, Volume: 98, Issue:1

    Topics: Adult; Aged; Cyclophosphamide; Drug Combinations; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Multivariate Analysis; Transplantation Conditioning

1997
Calphostin C synergistically induces apoptosis with VP-16 in lymphoma cells which express abundant phosphorylated Bcl-2 protein.
    Cellular and molecular life sciences : CMLS, 1997, Volume: 53, Issue:9

    Topics: Apoptosis; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; DNA Fragmentation; Drug Synergism; Etoposide; Humans; Lymphoma; Naphthalenes; Phosphoproteins; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Tetradecanoylphorbol Acetate; Translocation, Genetic; Tumor Cells, Cultured; Up-Regulation

1997
Topoisomerase II inhibitor-induced apoptosis in thymocytes and lymphoma cells.
    Advances in enzyme regulation, 1997, Volume: 37

    Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Apoptosis; Base Sequence; Cell Cycle; Cells, Cultured; DNA Fragmentation; DNA Topoisomerases, Type II; Enzyme Inhibitors; Etoposide; Gene Expression Regulation; Heterogeneous Nuclear Ribonucleoprotein A1; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Heterogeneous-Nuclear Ribonucleoproteins; Lymphoma; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Razoxane; Ribonucleoproteins; T-Lymphocytes; Thymus Gland; Topoisomerase II Inhibitors

1997
Apoptosis in the absence of cytochrome c accumulation in the cytosol.
    Biochemical and biophysical research communications, 1998, Jan-14, Volume: 242, Issue:2

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Biotin; Bleomycin; Blotting, Western; Camptothecin; Cytochrome c Group; Cytosol; Enzyme Inhibitors; Etoposide; Humans; Hydroxamic Acids; Lymphoma; Microscopy, Fluorescence; Mitochondria; Phalloidine; Poly(ADP-ribose) Polymerases; Staurosporine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vinblastine

1998
Treatment of multifocal lymphoma of bone with intensified ProMACE-CytaBOM chemotherapy and involved field radiotherapy.
    American journal of hematology, 1998, Volume: 58, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Tomography, X-Ray Computed; Vincristine

1998
Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.
    Hematological oncology, 1997, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fibrin Fibrinogen Degradation Products; Hodgkin Disease; Humans; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Mitoxantrone; Partial Thromboplastin Time; Plasminogen; Prednisone; Procarbazine; Protein C; Protein S; Thrombophilia; Time Factors; Vinblastine; Vincristine

1997
Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients.
    British journal of haematology, 1998, Volume: 102, Issue:4

    Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Colony-Forming Units Assay; Cytarabine; Dexamethasone; Etoposide; Female; Filgrastim; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Lymphoma; Male; Melphalan; Middle Aged; Recombinant Proteins; Retrospective Studies

1998
Degradation of eukaryotic polypeptide chain initiation factor (eIF) 4G in response to induction of apoptosis in human lymphoma cell lines.
    Oncogene, 1998, Dec-03, Volume: 17, Issue:22

    Topics: Amino Acid Chloromethyl Ketones; Antibodies; Apoptosis; Caspase Inhibitors; Caspases; Culture Media, Serum-Free; Cycloheximide; Etoposide; Eukaryotic Initiation Factor-4E; fas Receptor; Half-Life; Humans; Jurkat Cells; Lymphoma; Molecular Weight; Neoplasm Proteins; Oligopeptides; Peptide Initiation Factors; Poly(A)-Binding Proteins; Poly(ADP-ribose) Polymerases; Protein Synthesis Inhibitors; RNA-Binding Proteins; Sirolimus; Tumor Cells, Cultured

1998
High-dose sequential chemotherapy with autologous blood stem cell rescue for relapsed or resistant lymphoma.
    Schweizerische medizinische Wochenschrift, 1998, Oct-03, Volume: 128, Issue:40

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Stem Cells

1998
Ifosfamide and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.
    Bone marrow transplantation, 1999, Volume: 23, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infusions, Intravenous; Lymphoma; Male; Middle Aged; Prognosis; Transplantation, Autologous

1999
Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors.
    Journal of neuro-oncology, 1999, Volume: 42, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Cisplatin; Etoposide; Female; Glioblastoma; Hematoma; Humans; Infusions, Intra-Arterial; Lymphoma; Male; Middle Aged; Nausea; Retrospective Studies; Vomiting

1999
[Primary lymphoma of the thyroid with contralateral recurrence--case report].
    Wiener klinische Wochenschrift, 1999, Apr-23, Volume: 111, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Citrates; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Female; Gallium; Gallium Radioisotopes; Humans; Ifosfamide; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Radiopharmaceuticals; Remission Induction; Technetium; Thallium; Thyroid Neoplasms; Thyroidectomy; Vincristine

1999
Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma.
    Leukemia & lymphoma, 1999, Volume: 34, Issue:5-6

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Carmustine; Cyclophosphamide; Etoposide; Female; Fever; Hodgkin Disease; Humans; Length of Stay; Lymphoma; Male; Middle Aged; Neutropenia; Ofloxacin; Opportunistic Infections; Rifampin; Salvage Therapy

1999
Bcl-2 expression correlates with apoptosis induction but not tumor growth delay in transplantable murine lymphomas treated with different chemotherapy drugs.
    Cancer chemotherapy and pharmacology, 1999, Volume: 44, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Lymphoma; Male; Mice; Mice, Inbred C3H; Proto-Oncogene Proteins c-bcl-2

1999
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors.
    Blood, 2000, Mar-01, Volume: 95, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; California; Case-Control Studies; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Leukemia, Radiation-Induced; Lymphoma; Male; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Neoplasms, Second Primary; Odds Ratio; Radiotherapy; Retrospective Studies; Risk Factors; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation

2000
Hematopoietic recovery after IEV chemotherapy for malignant lymphoma followed by different cytokines can be monitored by analysis of Galpha 16 and CD34.
    American journal of hematology, 2000, Volume: 64, Issue:3

    Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cytokines; Epirubicin; Etoposide; Female; Gene Expression; GTP-Binding Protein alpha Subunits, Gq-G11; Hematopoiesis; Heterotrimeric GTP-Binding Proteins; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; RNA, Messenger; Time Factors

2000
Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders.
    Bone marrow transplantation, 2000, Volume: 26, Issue:2

    Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell Count; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Kinetics; Leukapheresis; Lymphoma; Lymphoproliferative Disorders; Male; Middle Aged; Regression Analysis; Salvage Therapy; Time Factors

2000
Epoch-cyclosporin A induces high response rates in relapsed lymphomas.
    Haematologica, 2000, Volume: 85, Issue:9

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Lymphoma; Male; Pilot Projects; Prednisone; Recurrence; Treatment Outcome; Vincristine

2000
Mobilization with etoposide and granulocyte colony-stimulating factor can replace bone marrow harvesting in patients with malignant lymphoma who previously failed to mobilize sufficient stem cells with cyclophosphamide and G-CSF.
    Journal of hematotherapy & stem cell research, 2000, Volume: 9, Issue:4

    Topics: Adult; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Etoposide; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Lymphoma; Middle Aged

2000
Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) sensitizes EBV-immortalized B cells to transforming growth factor-beta and chemotherapeutic agents.
    International journal of cancer, 2001, Jan-01, Volume: 91, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Apoptosis; B-Lymphocytes; Cell Division; Cell Line, Transformed; Cell Separation; Cyclin D2; Cyclins; Dexamethasone; DNA, Antisense; Down-Regulation; Etoposide; Flow Cytometry; Humans; Immunoblotting; Lymphoma; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Transforming Growth Factor beta; Tumor Cells, Cultured; Vincristine; Viral Matrix Proteins

2001
Identification of a caspase-2 isoform that behaves as an endogenous inhibitor of the caspase cascade.
    Cancer research, 2000, Dec-15, Volume: 60, Issue:24

    Topics: Amino Acid Sequence; Antineoplastic Agents, Phytogenic; Apoptosis; Base Sequence; Blotting, Southern; Blotting, Western; Caspase 2; Caspase Inhibitors; Caspases; Cell Death; Cell Line; Cell-Free System; Cloning, Molecular; Cytochrome c Group; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Etoposide; Humans; Kinetics; Lymphoma; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Nucleic Acid Synthesis Inhibitors; Precipitin Tests; Protein Binding; Protein Isoforms; Protein Structure, Tertiary; Recombinant Proteins; RNA, Messenger; Sequence Homology, Amino Acid; Time Factors; Tissue Distribution; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Two-Hybrid System Techniques

2000
Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.
    American journal of clinical pathology, 2001, Volume: 115, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Immunoenzyme Techniques; In Situ Hybridization; Killer Cells, Natural; Lymphoma; Male; Methotrexate; Middle Aged; Nose Neoplasms; Prednisone; Radiotherapy; RNA, Viral; Treatment Outcome; Vincristine

2001
Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents.
    The American journal of pathology, 2001, Volume: 159, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cesium Radioisotopes; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; DNA-Binding Proteins; Dose-Response Relationship, Radiation; Etoposide; Gamma Rays; Gene Expression Regulation, Enzymologic; Genes, p53; Genes, Tumor Suppressor; Humans; Jurkat Cells; Lymphoma; Reverse Transcriptase Polymerase Chain Reaction; Telomerase; Tumor Cells, Cultured; Tumor Suppressor Proteins; Vincristine

2001
ICE--an efficient drug combination for stem cell mobilization and high-dose treatment of malignant lymphoma.
    European journal of haematology. Supplementum, 2001, Volume: 64

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Etoposide; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Survival Rate; Therapeutic Equivalency

2001
Effects of adenoviral wild-type p53 gene transfer in p53-mutated lymphoma cells.
    Cancer gene therapy, 2001, Volume: 8, Issue:6

    Topics: Adenoviridae; Apoptosis; Cell Division; Cell Line; Etoposide; Flow Cytometry; Gene Transfer Techniques; Genes, p53; Green Fluorescent Proteins; Humans; Immunoblotting; Killer Cells, Natural; Luminescent Proteins; Lymphoma; Microscopy, Fluorescence; Mutation; Necrosis; Protein Synthesis Inhibitors; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Transduction, Genetic; Transfection

2001
Characteristics of etoposide-induced apoptotic cell death in the U-937 human lymphoma cell line.
    Anti-cancer drugs, 2001, Volume: 12, Issue:8

    Topics: Apoptosis; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Survival; DNA, Neoplasm; Etoposide; Humans; In Situ Nick-End Labeling; Kinetics; Lymphoma; Protein Biosynthesis; Signal Transduction; Tumor Cells, Cultured

2001
Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.
    Leukemia, 2002, Volume: 16, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Prognosis; Radiopharmaceuticals; Survival Analysis; Survival Rate; Tomography, Emission-Computed; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation

2002
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma.
    British journal of haematology, 2002, Volume: 116, Issue:1

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Purging; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Half-Life; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Metabolic Clearance Rate; Middle Aged; Polymerase Chain Reaction; Prednisone; Recurrence; Rituximab; Transplantation, Autologous; Vincristine

2002
Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation.
    Journal of cancer research and clinical oncology, 2002, Volume: 128, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Interferon-gamma; Interleukin-12; Interleukins; Lung Neoplasms; Lymphoma; Male; Middle Aged; Prednisone; Regression Analysis; T-Lymphocytes; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer; Time Factors; Tissue and Organ Harvesting; Transplantation, Autologous; Tumor Necrosis Factor-alpha; Vincristine

2002
Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation.
    Bone marrow transplantation, 2002, Volume: 29, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Chronic Disease; Combined Modality Therapy; Cyclophosphamide; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; In Situ Hybridization; Lymphoma; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous

2002
Cure in a case of primary hepatic lymphoma.
    Indian journal of cancer, 2000, Volume: 37, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Lymphoma; Male; Methotrexate; Prednisolone; Tomography, X-Ray Computed; Vincristine

2000
DNA damage-induced [Zn(2+)](i) transients: correlation with cell cycle arrest and apoptosis in lymphoma cells.
    American journal of physiology. Cell physiology, 2002, Volume: 283, Issue:2

    Topics: Apoptosis; Cell Cycle; Chelating Agents; Cytoplasm; DNA Damage; Ethylenediamines; Etoposide; Fluorescent Dyes; Humans; Lymphoma; Nucleic Acid Synthesis Inhibitors; Osmolar Concentration; Quinolones; Subcellular Fractions; Tosyl Compounds; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Zinc

2002
Evaluation of VP-16-213 in malignant lymphoma and melanoma.
    Cancer treatment reports, 1978, Volume: 62, Issue:5

    Topics: Adult; Drug Evaluation; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma; Male; Melanoma; Podophyllotoxin

1978
Survival and cycle-progression delay of human lymphoma cells in vitro exposed to VP-16-213.
    Cancer treatment reports, 1976, Volume: 60, Issue:9

    Topics: Cell Division; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Etoposide; Humans; Lymphoma; Neoplasms, Experimental; Podophyllotoxin

1976
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:12

    Topics: Adult; Ambulatory Care; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Diseases; Humans; Lymphoma; Male; Middle Aged; Multiple Myeloma; Recombinant Proteins

1992
Penetration of etoposide into human malignant brain tumors after intravenous and oral administration.
    Cancer chemotherapy and pharmacology, 1992, Volume: 29, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Brain Neoplasms; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Etoposide; Female; Glioma; Humans; Injections, Intravenous; Lymphoma; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Time Factors

1992
[Recent progress in the chemotherapy program and its theoretical background--malignant lymphoma].
    Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Prednisolone; Survival Rate; Vincristine

1992
Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor.
    Bone marrow transplantation, 1992, Volume: 10, Issue:4

    Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Blood Component Removal; Blood Transfusion, Autologous; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma; Male; Middle Aged; Recombinant Proteins

1992
Bone marrow purging in patients with refractory cancer.
    Progress in clinical and biological research, 1992, Volume: 377

    Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Child; Child, Preschool; Colony-Forming Units Assay; Etoposide; Female; Hematopoietic Stem Cells; Humans; In Vitro Techniques; Leukemia; Lymphoma; Male; Methylprednisolone; Middle Aged; Neoplasms; Transplantation, Autologous

1992
Ablative therapy in bone marrow transplantation.
    Bone marrow transplantation, 1991, Volume: 7 Suppl 1

    Topics: Bone Marrow Transplantation; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Lymphoma

1991
Pneumothorax following cytotoxic chemotherapy in malignant lymphoma.
    Chest, 1990, Volume: 98, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Humans; Lung; Lung Neoplasms; Lymphoma; Male; Methotrexate; Middle Aged; Pneumothorax; Prednisone; Procarbazine; Radiography; Vinblastine; Vincristine

1990
Etoposide, ifosfamide, and methotrexate with or without bleomycin in refractory or recurrent lymphomas.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Remission Induction; Survival Rate

1991
Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro.
    Anti-cancer drug design, 1991, Volume: 6, Issue:5

    Topics: Animals; Bleomycin; Drug Synergism; Etoposide; Humans; Indomethacin; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipoxygenase Inhibitors; Lung Neoplasms; Lymphoma; Methotrexate; Neoplasms, Experimental; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostaglandins; Protein Kinase Inhibitors; Tumor Cells, Cultured

1991
Experience with salvage regimens at M.D. Anderson Hospital.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Methylprednisolone; Methylprednisolone Hemisuccinate; Mitoguazone; Mitoxantrone; Remission Induction; Survival Rate

1991
Massively bleeding gastrosplenic fistula following cytostatic chemotherapy of a malignant lymphoma.
    Journal of clinical gastroenterology, 1991, Volume: 13, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Fistula; Gastric Fistula; Gastrointestinal Hemorrhage; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Splenic Diseases; Stomach Neoplasms

1991
Elimination of clonogenic tumor cells from bone marrow using methylprednisolone (MP) and etoposide VP16: an in vitro pharmacologic study.
    International journal of cell cloning, 1991, Volume: 9, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Cell Death; Cell Separation; Dose-Response Relationship, Drug; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma; Methylprednisolone; Tumor Cells, Cultured

1991
Chronic daily administration of oral etoposide in refractory lymphoma.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:7

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Thrombocytopenia

1990
Infusion of high doses of undiluted etoposide through central venous catheters during preparation for bone marrow transplantation.
    Cancer investigation, 1990, Volume: 8, Issue:1

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Bone Marrow Transplantation; Carcinoma, Non-Small-Cell Lung; Catheterization, Central Venous; Colonic Neoplasms; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Middle Aged; Neoplasms

1990
Pharmacokinetics of very high-dose oral melphalan in cancer patients.
    American journal of clinical oncology, 1990, Volume: 13, Issue:1

    Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Bone Marrow Transplantation; Carmustine; Etoposide; Female; Humans; Injections, Intravenous; Lymphoma; Male; Melanoma; Melphalan; Middle Aged; Time Factors

1990
The results of Vepesid therapy in the treatment of malignant lymphomas.
    Neoplasma, 1990, Volume: 37, Issue:1

    Topics: Adult; Aged; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged

1990
BVAC ablative chemotherapy followed by autologous bone marrow transplantation for patients with advanced lymphoma.
    Blood, 1990, Jun-15, Volume: 75, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Humans; Lymphoma; Middle Aged; Survival Analysis; Time Factors

1990
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy.
    Blood, 1990, Aug-01, Volume: 76, Issue:3

    Topics: Acute Disease; Blood Cells; Bone Marrow Transplantation; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Etoposide; Hodgkin Disease; Humans; Leukemia; Lymphoma; Spleen

1990
In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
    Experimental hematology, 1990, Volume: 18, Issue:9

    Topics: Bone Marrow; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma; Nitrogen Mustard Compounds; Tumor Cells, Cultured

1990
Management of advanced, resistant Hodgkin's disease and non-Hodgkin's lymphoma: a phase II study.
    Cancer treatment reports, 1986, Volume: 70, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Evaluation; Etoposide; Hodgkin Disease; Humans; Leucovorin; Lomustine; Lung Diseases; Lymphoma; Middle Aged

1986
Hematologic malignancies: non-Hodgkin's lymphomas.
    Hospital practice (Office ed.), 1986, Sep-15, Volume: 21, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vinblastine; Vincristine

1986
The simultaneous presentation of peripheral T-cell lymphoma and hairy cell leukemia.
    Cancer, 1987, Oct-01, Volume: 60, Issue:7

    Topics: Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Head and Neck Neoplasms; Histocytochemistry; HLA-DR Antigens; Humans; Leukemia, Hairy Cell; Lymphatic Metastasis; Lymphoma; Microscopy, Electron; Middle Aged; Prednisone; Procarbazine; Scalp; T-Lymphocytes; Vincristine

1987
Comparative regimens for the ex vivo chemopurification of B cell lymphoma-contaminated marrow.
    Acta haematologica, 1988, Volume: 80, Issue:2

    Topics: Antineoplastic Agents; B-Lymphocytes; Bleomycin; Bone Marrow; Cell Line; Cell Separation; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma; Mechlorethamine; Vincristine

1988
[Salvage chemotherapy with a combination of VP-16, ifosfamide, procarbazine, prednisolone, bleomycin and methotrexate (VIPP-BM) for refractory malignant lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Middle Aged; Prednisolone; Procarbazine

1989
Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoietic disorders.
    Cancer, 1989, Aug-01, Volume: 64, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Endocrine System Diseases; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Libido; Lymphoma; Male; Menstruation Disturbances; Middle Aged; Ovarian Diseases; Whole-Body Irradiation

1989
Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16.
    Japanese journal of cancer research : Gann, 1989, Volume: 80, Issue:10

    Topics: Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dactinomycin; Daunorubicin; Doxorubicin; Drug Resistance; Etoposide; Gene Expression; Humans; Leukemia; Lymphoma; Membrane Glycoproteins; Mitoxantrone; RNA, Messenger; Tumor Cells, Cultured; Vinblastine; Vincristine; Vindesine

1989
ProMACE-MOPP combination chemotherapy for diffuse lymphomas.
    Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vincristine

1985
New conditioning regimens for high risk marrow transplants.
    Bone marrow transplantation, 1989, Volume: 4 Suppl 4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporins; Drug Evaluation; Etoposide; Graft vs Host Disease; Humans; Leukemia; Lymphoma; Middle Aged

1989
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission Induction; Vincristine

1989
Etoposide: a pharmacokinetic profile including an assessment of bioavailability.
    Medical oncology and tumor pharmacotherapy, 1986, Volume: 3, Issue:2

    Topics: Administration, Oral; Biological Availability; Carcinoma; Carcinoma, Small Cell; Etoposide; Female; Hodgkin Disease; Humans; Injections, Intravenous; Kinetics; Lung Neoplasms; Lymphoma; Male; Neoplasms; Podophyllotoxin

1986
Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.
    Seminars in hematology, 1988, Volume: 25, Issue:2 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Evaluation; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Methylprednisolone; Mitoguazone; Transplantation, Autologous

1988
Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies.
    Cancer chemotherapy and pharmacology, 1988, Volume: 22, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematologic Diseases; Humans; Leukemia, Lymphoid; Lymphoma; Male; Melphalan; Middle Aged; Recurrence; Remission Induction; Thymoma; Thymus Neoplasms

1988
Ifosfamide and VP-16213 combination chemotherapy combined with ablative chemotherapy and autologous marrow transplantation as salvage treatment for malignant lymphoma.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma; Melphalan; Methotrexate; Middle Aged; Mitoguazone; Podophyllotoxin

1988
Salvage chemotherapy for lymphoma with VP-16, ifosfamide, and cisplatin.
    Medical and pediatric oncology, 1988, Volume: 16, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; Etoposide; Hematopoiesis; Humans; Ifosfamide; Lymphoma; Middle Aged; Risk Factors

1988
[Phase II study of etoposide (VP-16) in the form of intravenous injection for malignant lymphomas and acute leukemias: Hanshin Cooperative Study Group for Hematological Disorders].
    Gan no rinsho. Japan journal of cancer clinics, 1987, Volume: 33, Issue:1

    Topics: Adult; Aged; Drug Evaluation; Etoposide; Female; Hodgkin Disease; Humans; Injections, Intravenous; Leukemia; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged

1987
Etoposide as an in vitro purging agent for the treatment of acute leukemias and lymphomas in conjunction with autologous bone marrow transplantation.
    Experimental hematology, 1986, Volume: 14, Issue:7

    Topics: Bone Marrow; Bone Marrow Transplantation; Colony-Forming Units Assay; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma; Microscopy, Electron; Podophyllotoxin; Transplantation, Autologous

1986
In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy.
    Cancer chemotherapy and pharmacology, 1987, Volume: 19, Issue:3

    Topics: Carcinoma, Bronchogenic; Cell Line; Cell Survival; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Etoposide; Humans; Lung Neoplasms; Lymphoma; Regression Analysis; Tumor Stem Cell Assay

1987
Etoposide and cisplatinum in resistant lymphomas.
    Cancer chemotherapy and pharmacology, 1987, Volume: 20, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged

1987
[Etoposide in the treatment of recurrent malignant lymphoma].
    Vnitrni lekarstvi, 1986, Volume: 32, Issue:4

    Topics: Adolescent; Adult; Aged; Etoposide; Hodgkin Disease; Humans; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin

1986
[A case of coexisting primary malignant lymphoma and adenocarcinoma of the stomach].
    Gan no rinsho. Japan journal of cancer clinics, 1986, Volume: 32, Issue:4

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrectomy; Gastroscopy; Humans; Lymphoma; Neoplasms, Multiple Primary; Prednisolone; Stomach; Stomach Neoplasms; Vinblastine; Vincristine

1986
Preclinical assessment of purging with VP-16-213: key role for long-term marrow cultures.
    Blood, 1987, Volume: 69, Issue:1

    Topics: Bone Marrow; Cells, Cultured; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma

1987
Salvage chemotherapy of advanced lymphoma with investigational drugs: mitoguazone, gallium nitrate, and etoposide.
    Cancer treatment reports, 1987, Volume: 71, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Gallium; Humans; Lymphoma; Middle Aged; Mitoguazone

1987
Results of MIME salvage regimen for recurrent or refractory lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Mitoguazone; Prognosis; Remission Induction

1987
[A phase II trial of etoposide (VP-16) administered intravenously in the treatment of malignant lymphoma and acute leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1985, Volume: 26, Issue:11

    Topics: Acute Disease; Adolescent; Adult; Aged; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Leukemia; Lymphoma; Male; Middle Aged; Podophyllotoxin

1985
[VP 16-213].
    Gan no rinsho. Japan journal of cancer clinics, 1985, Volume: 31, Issue:6 Suppl

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Humans; Leucovorin; Lymphoma; Methotrexate; Podophyllotoxin; Prednisolone

1985
Ifosfamide and etoposide as salvage therapy for non-Hodgkin's lymphoma.
    Scandinavian journal of haematology, 1986, Volume: 36, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Podophyllotoxin; Recurrence

1986
[Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:3 Pt 1

    Topics: Acute Disease; Adolescent; Adult; Aged; Alopecia; Anorexia; Drug Evaluation; Etoposide; Fatigue; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Nausea; Podophyllotoxin

1986
[Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:4 Pt 1

    Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Leukemia; Lymphoma; Male; Myeloproliferative Disorders; Podophyllotoxin

1986
[ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:4 Pt 1

    Topics: Aclarubicin; Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Naphthacenes; Prednisolone; Thrombocytopenia; Vincristine

1986
A case report and description of the pharmacokinetic behavior of intrapleurally instilled etoposide.
    Cancer chemotherapy and pharmacology, 1985, Volume: 14, Issue:2

    Topics: Absorption; Chromatography, High Pressure Liquid; Diffusion; Etoposide; Female; Humans; Kinetics; Lymphoma; Middle Aged; Pleural Effusion; Podophyllotoxin

1985
Vindesine, etoposide (VP-16), and prednisolone (VEP) in relapsed patients with grade II non-Hodgkin's lymphoma.
    Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Prednisolone; Vinblastine; Vindesine

1985
VP-16 in the treatment of malignant lymphomas: a report from the Swiss Group for Clinical Cancer Research (SAKK).
    Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Etoposide; Humans; Lymphoma; Middle Aged; Pilot Projects; Podophyllotoxin

1985
[Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:7

    Topics: Administration, Oral; Adult; Aged; Capsules; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Podophyllotoxin; Thrombocytopenia

1985
Cis-dichlorodiammineplatinum (cis-platinum) and etoposide (VP-16) in malignant lymphoma--an effective salvage regimen.
    Cancer chemotherapy and pharmacology, 1985, Volume: 14, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Kidney; Lymphoma; Male; Middle Aged

1985
[Mitoxantrone in the treatment of relapsed and refractory malignant lymphoma].
    Gan no rinsho. Japan journal of cancer clinics, 1985, Volume: 31, Issue:6 Suppl

    Topics: Adult; Anthraquinones; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Evaluation; Drug Resistance; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Mitoxantrone; Prednisolone; Recurrence

1985